v3.24.1.u1
COVER PAGE - shares
3 Months Ended
Mar. 31, 2024
May 07, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-35517  
Entity Registrant Name ARES COMMERCIAL REAL ESTATE CORPORATION  
Entity Incorporation, State or Country Code MD  
Entity Tax Identification Number 45-3148087  
Entity Address, Address Line One 245 Park Avenue  
Entity Address, Address Line Two 42nd Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10167  
City Area Code 212  
Local Phone Number 750-7300  
Title of 12(b) Security Common stock, $0.01 par value per share  
Trading Symbol ACRE  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   54,506,811
Entity Central Index Key 0001529377  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
v3.24.1.u1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Cash and cash equivalents $ 99,518 $ 110,459
Loans held for investment ($773,904 and $892,166 related to consolidated VIEs, respectively) 2,014,500 2,126,524
Current expected credit loss reserve (139,763) (159,885)
Loans held for investment, net of current expected credit loss reserve 1,874,737 1,966,639
Loans held for sale, at fair value ($38,981 related to consolidated VIEs as of December 31, 2023) 0 38,981
Investment in available-for-sale debt securities, at fair value 28,148 28,060
Real estate owned, net 82,499 83,284
Other assets ($3,537 and $3,690 of interest receivable related to consolidated VIEs, respectively; $6,539 and $32,002 of other receivables related to consolidated VIEs, respectively) 25,795 52,354
Total assets 2,110,697 2,279,777
LIABILITIES    
Secured funding agreements 630,299 639,817
Notes payable 104,714 104,662
Secured term loan 149,443 149,393
Collateralized loan obligation securitization debt (consolidated VIEs) 595,105 723,117
Due to affiliate 4,281 4,135
Dividends payable 13,802 18,220
Other liabilities ($1,918 and $2,263 of interest payable related to consolidated VIEs, respectively) 11,964 14,584
Other liabilities ($1,918 and $2,263 of interest payable related to consolidated VIEs, respectively) 11,964 14,584
Total liabilities 1,509,608 1,653,928
Commitments and contingencies (Note 8)
STOCKHOLDERS' EQUITY    
Common stock, par value $0.01 per share, 450,000,000 shares authorized at March 31, 2024 and December 31, 2023 and 54,422,613 and 54,149,225 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 532 532
Additional paid-in capital 813,468 812,184
Accumulated other comprehensive income 234 153
Accumulated earnings (deficit) (213,145) (187,020)
Total stockholders' equity 601,089 625,849
Total liabilities and stockholders' equity $ 2,110,697 $ 2,279,777
v3.24.1.u1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Loans held for investment $ 2,014,500 $ 2,126,524
Loans held for sale 0 38,981
Other assets 25,795 52,354
Payable $ 11,964 $ 14,584
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 54,422,613 54,149,225
Common stock, shares outstanding (in shares) 54,422,613 54,149,225
Variable Interest Entity, Primary Beneficiary    
Loans held for investment $ 773,904,000 $ 892,166,000
Loans held for sale   38,981
Interest receivable 3,537,000 3,690,000
Other assets 6,539,000 32,002,000
Payable $ 1,918,000 $ 2,263,000
v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Interest income $ 44,033 $ 49,500
Interest expense (28,819) (22,999)
Net interest margin 15,214 26,501
Revenue from real estate owned 3,478 0
Total revenue 18,692 26,501
Expenses:    
Management and incentive fees to affiliate 2,768 3,010
Professional fees 533 771
General and administrative expenses 2,081 1,685
General and administrative expenses reimbursed to affiliate 1,132 732
Expenses from real estate owned 2,037 0
Total expenses 8,551 6,198
Provision for current expected credit losses (22,269) 21,019
Realized losses on loans 45,726 5,613
Change in unrealized losses on loans held for sale (995) 0
Income (loss) before income taxes (12,321) (6,329)
Income tax expense, including excise tax 2 110
Net income (loss) attributable to common stockholders $ (12,323) $ (6,439)
Earnings (loss) per common share:    
Basic earnings (loss) per common share (in dollars per share) $ (0.23) $ (0.12)
Diluted earnings (loss) per common share (in dollars per share) $ (0.23) $ (0.12)
Weighted average number of common shares outstanding:    
Basic weighted average shares of common stock outstanding (in shares) 54,396,397 54,591,650
Diluted weighted average shares of common stock outstanding (in shares) 54,396,397 54,591,650
Dividends per share amount declared (in dollars per share) $ 0.25 $ 0.35
v3.24.1.u1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net income (loss) attributable to common stockholders $ (12,323) $ (6,439)
Other comprehensive income (loss):    
Realized and unrealized gains (losses) on derivative financial instruments 0 (4,477)
Unrealized gains on available-for-sale debt securities 81 65
Comprehensive income (loss) $ (12,242) $ (10,851)
v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2022   54,443,983,000      
Beginning balance at Dec. 31, 2022 $ 747,540 $ 537 $ 812,788 $ 7,541 $ (73,326)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation (in shares)   162,843,000      
Stock‑based compensation 960   960    
Other comprehensive income (loss) (4,412)     (4,412)  
Net income (loss) (6,439)       (6,439)
Dividends declared (19,346)       (19,346)
Ending balance (in shares) at Mar. 31, 2023   54,606,826,000      
Ending balance at Mar. 31, 2023 718,303 $ 537 813,748 3,129 (99,111)
Increase (Decrease) in Stockholders' Equity          
Offering costs (4)   4    
Stock-based compensation (in shares)   65,412,000      
Stock‑based compensation 1,004   1,004    
Repurchase and retirement of common stock (in shares)   (535,965,000)      
Repurchase and retirement of common stock (4,600) $ (5) (4,595)    
Other comprehensive income (loss) (2,142)     (2,142)  
Net income (loss) (2,198)       (2,198)
Dividends declared (19,180)       (19,180)
Ending balance (in shares) at Jun. 30, 2023   54,136,273,000      
Ending balance at Jun. 30, 2023 691,191 $ 532 810,161 987 (120,489)
Increase (Decrease) in Stockholders' Equity          
Stock‑based compensation 986   986    
Other comprehensive income (loss) (321)     (321)  
Net income (loss) 9,184       9,184
Dividends declared (18,082)       (18,082)
Ending balance (in shares) at Sep. 30, 2023   54,136,273,000      
Ending balance at Sep. 30, 2023 682,958 $ 532 811,147 666 (129,387)
Increase (Decrease) in Stockholders' Equity          
Offering costs (4)   (4)    
Stock-based compensation (in shares)   12,952,000      
Stock‑based compensation 1,041   1,041    
Other comprehensive income (loss) (513)     (513)  
Net income (loss) (39,414)       (39,414)
Dividends declared $ (18,219)       (18,219)
Ending balance (in shares) at Dec. 31, 2023 54,149,225 54,149,225,000      
Ending balance at Dec. 31, 2023 $ 625,849 $ 532 812,184 153 (187,020)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation (in shares)   273,388,000      
Stock‑based compensation 1,284   1,284    
Other comprehensive income (loss) 81     81  
Net income (loss) (12,323)       (12,323)
Dividends declared $ (13,802)       (13,802)
Ending balance (in shares) at Mar. 31, 2024 54,422,613 54,422,613,000      
Ending balance at Mar. 31, 2024 $ 601,089 $ 532 $ 813,468 $ 234 $ (213,145)
v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Operating activities:        
Net income (loss) $ (12,323) $ (39,414) $ (2,198) $ (6,439)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Amortization of deferred financing costs 1,118     979
Accretion of discounts, deferred loan origination fees and costs (1,254)     (1,779)
Stock-based compensation 1,284     960
Depreciation and amortization of real estate owned 786     0
Provision for current expected credit losses (22,269)     21,019
Realized losses on loans 45,726     5,613
Change in unrealized losses on loans held for sale (995)     0
Amortization of derivative financial instruments 0     (456)
Changes in operating assets and liabilities:        
Other assets (493)     (8,617)
Due to affiliate 146     (1,681)
Other liabilities (348)     1,657
Net cash provided by (used in) operating activities 11,378     11,256
Investing activities:        
Issuance of and fundings on loans held for investment (12,003)     (18,378)
Principal collections and cost-recovery proceeds on loans held for investment 106,806     78,198
Proceeds from sale of loans held for sale 38,981     9,825
Receipt of origination and other loan fees 232     413
Net cash provided by (used in) investing activities 134,016     70,058
Financing activities:        
Proceeds from secured funding agreements 12,781     12,662
Repayments of secured funding agreements (22,299)     (19,740)
Payment of secured funding costs (370)     (297)
Repayments of debt of consolidated VIEs (128,226)     (42,106)
Dividends paid (18,221)     (19,347)
Net cash provided by (used in) financing activities (156,335)     (68,828)
Change in cash and cash equivalents (10,941)     12,486
Cash and cash equivalents, beginning of period 110,459   $ 153,764 141,278
Cash and cash equivalents, end of period 99,518 $ 110,459   153,764
Supplemental disclosure of noncash investing and financing activities:        
Dividends declared, but not yet paid 13,802     19,346
Other receivables related to consolidated VIEs $ 6,539     $ 128,334
v3.24.1.u1
ORGANIZATION
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION ORGANIZATION
Ares Commercial Real Estate Corporation (together with its consolidated subsidiaries, the “Company” or “ACRE”) is a specialty finance company primarily engaged in originating and investing in commercial real estate loans and related investments. Through Ares Commercial Real Estate Management LLC (“ACREM” or the Company’s “Manager”), a Securities and Exchange Commission (“SEC”) registered investment adviser and a subsidiary of Ares Management Corporation (NYSE: ARES) (“Ares Management” or “Ares”), a publicly traded, leading global alternative investment manager, it has investment professionals strategically located across the United States and Europe who directly source new loan opportunities for the Company with owners, operators and sponsors of commercial real estate (“CRE”) properties. The Company was formed and commenced operations in late 2011. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in May 2012. The Company is externally managed by its Manager, pursuant to the terms of a management agreement (the “Management Agreement”).
 
The Company operates as one operating segment and is primarily focused on directly originating and managing a diversified portfolio of CRE debt-related investments for the Company’s own account. The Company’s target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investments, including commercial mortgage-backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, self storage, student housing, residential and other commercial real estate properties, or by ownership interests therein.

The Company has elected and qualified to be taxed as a real estate investment trust (“REIT”) for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2012. The Company generally will not be subject to United States federal income taxes on its REIT taxable income as long as it annually distributes all of its REIT taxable income prior to the deduction for dividends paid to stockholders and complies with various other requirements as a REIT.
v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and the related management's discussion and analysis of financial condition and results of operations included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC.

Refer to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 for a description of the Company’s recurring accounting policies. The Company has included disclosure below regarding basis of presentation and other accounting policies that (i) are required to be disclosed quarterly or (ii) the Company views as critical as of the date of this report.

Basis of Presentation

The accompanying unaudited consolidated interim financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The unaudited consolidated interim financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

The unaudited consolidated interim financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The current period’s results of operations will not necessarily be indicative of results for any other interim period or that ultimately may be achieved for the year ending December 31, 2024.
Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Global macroeconomic conditions, including high inflation, changes to fiscal and monetary policy, high interest rates, potential market-wide liquidity problems, currency fluctuations, labor shortages and challenges in the supply chain, have the potential to negatively impact the Company and its borrowers. These current macroeconomic conditions may continue or aggravate and could cause the United States economy or other global economies to experience an economic slowdown or recession. We anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States or other major global economy.

The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2024, however, uncertainty over the global economy and the Company’s business, makes any estimates and assumptions as of March 31, 2024 inherently less certain than they would be absent the current and potential impacts of current macroeconomic conditions. Actual results could differ from those estimates.

Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.
 
To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.

For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.

The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 15 included in these consolidated financial statements for further discussion of the Company’s VIEs.

Cash and Cash Equivalents

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.
Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds (the “carrying value”). Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to reduce loan carrying value depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Loan balances that are deemed to be uncollectible are written off as a realized loss and are deducted from the current expected credit loss reserve. The write-offs are recorded in the period in which the loan balance is deemed uncollectible based on management’s judgment.

Current Expected Credit Losses

FASB ASC Topic 326, Financial Instruments—Credit Losses (“ASC 326”), requires the Company to reflect current expected credit losses (“CECL”) on both the outstanding balances and unfunded commitments on loans held for investment and requires consideration of a broad range of historical experience adjusted for current conditions and reasonable and supportable forecast information to inform credit loss estimates (the “CECL Reserve” or “CECL Reserves”). Increases and decreases to expected credit losses impact earnings and are recorded within provision for current expected credit losses in the Company’s consolidated statements of operations. The CECL Reserve related to outstanding balances on loans held for investment required under ASC 326 is a valuation account that is deducted from the amortized cost basis of the Company’s loans held for investment in the Company’s consolidated balance sheets. The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company’s consolidated balance sheets. See Note 4 included in these consolidated financial statements for CECL related disclosures.

Loans Held for Sale

Although the Company generally holds its target investments as long-term investments, the Company occasionally classifies some of its investments as held for sale. Investments held for sale are carried at fair value within loans held for sale, at fair value in the Company’s consolidated balance sheets, with changes in fair value recorded through earnings.

Real Estate Owned

Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation or amortization and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, buildings and improvements, furniture, fixtures and equipment, intangible assets and intangible liabilities, as applicable.
Real estate assets are depreciated or amortized using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements, up to 15 years for furniture, fixtures and equipment and over the lease terms for intangible assets and liabilities. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred. Other than amortization related to intangible assets and liabilities for above-market or below-market leases, depreciation or amortization expense related to real estate assets is included within expenses from real estate owned in the Company’s consolidated statements of operations. Amortization for above-market or below-market leases is recognized as an adjustment to rental revenue and is included within revenue from real estate owned in the Company’s consolidated statements of operations.

Real estate assets are evaluated for indicators of impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate.

The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being actively marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.

Available-for-Sale Debt Securities

The Company acquires debt securities that are collateralized by mortgages on CRE properties primarily for short-term cash management and investment purposes. On the acquisition date, the Company designates investments in CRE debt securities as available-for-sale. Investments in CRE debt securities that are classified as available-for-sale are carried at fair value. Unrealized holding gains and losses for available-for-sale debt securities are recorded each period in other comprehensive income (“OCI”). The Company uses a specific identification method when determining the cost of a debt security sold and the amount of unrealized gain or loss reclassified from accumulated other comprehensive income (loss) into earnings.

Available-for-sale debt securities that are in an unrealized loss position are evaluated on a quarterly basis to determine whether declines in the fair value below the amortized cost basis qualify as other than temporary impairment (“OTTI”). The OTTI assessment is performed at the individual security level. In assessing whether the entire amortized cost basis of each security will be recovered, the Company will compare the present value of cash flows expected to be collected from the security with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the entire amortized cost basis of the security will not be recovered and an OTTI shall be considered to have occurred.

Available-for-sale debt securities are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the debt security is placed on non-accrual status. Interest payments received on non-accrual securities may be recognized as income or applied to reduce amortized cost basis depending upon management’s judgment regarding collectability of the debt security. Non-accrual debt securities are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current.

Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of
the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on the (i) Secured Funding Agreements (each individually defined in Note 6 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable, the Secured Term Loan (each defined in Note 6 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets.

Derivative Financial Instruments

Derivative financial instruments are classified as either other assets (gain positions) or other liabilities (loss positions) in the Company’s consolidated balance sheets at fair value. These amounts may be offset to the extent that there is a legal right to offset and if elected by management.

On the date the Company enters into a derivative contract, the Company designates each contract as a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability, or cash flow hedge, or as a derivative instrument not to be designated as a hedging derivative, or non-designated hedge. For all derivatives other than those designated as non-designated hedges, the Company formally documents the hedge relationships and designation at the contract’s inception. This documentation includes the identification of the hedging instruments and the hedged items, its risk management objectives, strategy for undertaking the hedge transaction and an evaluation of the effectiveness of its hedged transaction.

The Company performs a formal assessment on a quarterly basis on whether the derivative designated in each hedging relationship is expected to be, and has been, highly effective in offsetting changes in the value or cash flows of the hedged items. Changes in the fair value of derivative contracts are recorded each period in either current earnings or OCI, depending on whether the derivative is designated as part of a hedge transaction and, if so, the type of hedge transaction. For derivatives that are designated as cash flow hedges, the effective portion of the unrealized gains or losses on these contracts is recorded in OCI. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued and the changes in fair value of the instrument are included in current earnings prospectively. The Company does not enter into derivatives for trading or speculative purposes.

Revenue Recognition

Interest income is accrued based on the outstanding principal amount and the contractual terms of each loan or debt security. For loans held for investment, the origination fees, contractual exit fees and direct origination costs are also recognized in interest income over the initial loan term as a yield adjustment using the effective interest method. For available-for-sale debt securities, premiums or discounts are amortized or accreted into interest income as a yield adjustment using the effective interest method.

    Revenue from real estate owned represents revenue associated with the operations of a mixed-use property classified as real estate owned that was acquired in September 2023.

Revenue from the operation of the mixed-use property consists primarily of rental revenue from operating leases. For each operating lease with scheduled rent increases over the term of the lease, the Company recognizes rental revenue on a straight-line basis over the lease term when collectability of the lease payment is probable. Variable lease payments are recognized as rental revenue in the period when the changes in facts and circumstances on which the variable lease payments are based occur. Certain of the Company’s mixed-use property leases also contain provisions for tenants to reimburse the Company for property operating expenses. Such reimbursements are included in rental revenue on a gross basis. Rental revenue also includes amortization of intangible assets and liabilities related to above and below-market leases.
Net Interest Margin and Interest Expense
Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans and debt securities as compared to its use of debt leverage. The Company includes interest income from its loans and debt securities and interest expense related to its Secured Funding Agreements, Notes Payable, securitization debt and the Secured Term Loan (each individually defined in Note 6 included in these consolidated financial statements) in net interest margin. For the three months ended March 31, 2024 and 2023, interest expense is comprised of the following ($ in thousands):
For the Three Months Ended March 31,
 20242023
Secured funding agreements $12,877 $12,311 
Notes payable1,999 1,759 
Securitization debt12,187 11,606 
Secured term loan1,756 1,734 
Other (1)— (4,411)
Interest expense$28,819 $22,999 
______________________________
(1)    Represents the net interest expense recognized from the Company’s derivative financial instruments upon periodic settlement.
Comprehensive Income
Comprehensive income consists of net income (loss) and OCI that are excluded from net income (loss).
v3.24.1.u1
LOANS HELD FOR INVESTMENT
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
LOANS HELD FOR INVESTMENT LOANS HELD FOR INVESTMENT
As of March 31, 2024, the Company’s portfolio included 44 loans held for investment, excluding 170 loans that were repaid, sold or converted to real estate owned since inception. The aggregate originated commitment under these loans at closing was approximately $2.2 billion and outstanding principal was $2.0 billion as of March 31, 2024. During the three months ended March 31, 2024, the Company funded approximately $13.0 million of outstanding principal and received repayments of $78.4 million of outstanding principal. As of March 31, 2024, 70.0% of the Company’s loans have Secured Overnight Financing Rate (“SOFR”) floors, with a weighted average floor of 1.17%, calculated based on loans with SOFR floors. References to SOFR or “S” are to 30-day SOFR (unless otherwise specifically stated).
 
The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of March 31, 2024 and December 31, 2023 ($ in thousands):

 As of March 31, 2024
Carrying Amount (1)Outstanding Principal (1)Weighted Average Unleveraged Effective YieldWeighted Average Remaining Life (Years)
Senior mortgage loans $1,970,558 $1,996,099 8.0 %(2)9.2 %(3)1.0
Subordinated debt and preferred equity investments43,942 48,849 6.4 %(2)15.3 %(3)1.9
Total loans held for investment portfolio $2,014,500 $2,044,948 7.9 %(2)9.3 %(3)1.0
 As of December 31, 2023
Carrying Amount (1)
Outstanding Principal (1)
Weighted Average Unleveraged Effective YieldWeighted Average Remaining Life (Years)
Senior mortgage loans $2,090,146 $2,118,947 7.5 %(2)9.3 %(3)1.1
Subordinated debt and preferred equity investments36,378 39,098 8.1 %(2)15.3 %(3)1.8
Total loans held for investment portfolio$2,126,524 $2,158,045 7.5 %(2)9.4 %(3)1.1
______________________________

(1)The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds.
(2)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of March 31, 2024 and December 31, 2023 as weighted by the total outstanding principal balance of each loan.
(3)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all interest accruing loans held by the Company as of March 31, 2024 and December 31, 2023 as weighted by the total outstanding principal balance of each interest accruing loan (excludes loans on non-accrual status as of March 31, 2024 and December 31, 2023).
A more detailed listing of the Company’s loans held for investment portfolio based on information available as of March 31, 2024 is as follows ($ in millions):

Loan Type
LocationOutstanding Principal (1)Carrying Amount (1)Interest RateUnleveraged Effective Yield (2)Maturity Date (3)Payment Terms (4)
Senior Mortgage Loans:
OfficeIL$160.2$154.0(5)7.6%(5)Mar 2025I/O
MultifamilyNY132.2131.5S+3.90%9.7%Jun 2025I/O
OfficeDiversified109.0108.8S+3.75%9.3%Jan 2025P/I(6)
IndustrialIL100.7100.7S+4.65%10.4%May 2024I/O
MultifamilyTX97.597.1S+3.00%(7)8.8%Jul 2025I/O
Residential/CondoNY96.288.3S+8.95%—%(8)Dec 2025(8)I/O
Mixed-useNY76.376.3S+3.75%9.4%Jul 2024I/O
Residential/CondoFL75.075.0S+5.35%10.7%Jul 2024I/O
OfficeAZ71.871.6S+3.61%9.4%Oct 2024I/O
OfficeNC68.968.8S+3.65%9.4%Aug 2024I/O
OfficeNC68.665.5S+4.35%—%(9)May 2024(9)P/I(6)
MultifamilyTX68.468.3S+2.95%8.7%Dec 2024I/O
Multifamily/OfficeSC67.066.9S+3.00%8.6%Nov 2024I/O
OfficeNY59.059.0S+2.65%8.0%(10)Jul 2027(10)I/O
MultifamilyOH57.056.5S+3.05%8.8%Oct 2026I/O
OfficeIL56.055.8S+4.25%10.1%Jan 2025I/O
HotelNY52.952.6S+4.40%10.1%Mar 2026I/O
HotelCA50.950.7S+4.20%10.0%Mar 2025I/O
OfficeMA50.149.7S+3.75%9.9%Apr 2025I/O
OfficeGA48.448.3S+3.15%8.7%Dec 2024P/I(6)
IndustrialMA47.547.2S+2.90%8.4%Jun 2028I/O
Mixed-useTX35.335.3S+3.85%9.4%Sep 2024I/O
OfficeCA33.230.6S+3.45%—%(11)Dec 2023(11)I/O
MultifamilyCA31.731.6S+3.00%8.6%Dec 2025I/O
MultifamilyPA28.228.2S+2.50%7.8%Dec 2025I/O
IndustrialNJ27.827.8S+3.85%9.8%May 2024I/O
IndustrialFL25.525.4S+3.00%8.6%Dec 2025I/O
MultifamilyWA23.123.0S+3.00%8.5%Nov 2025I/O
MultifamilyTX23.023.0S+2.60%8.3%Oct 2024I/O
OfficeCA20.420.3S+3.50%9.1%Nov 2025P/I(6)
IndustrialCA19.618.7S+3.85%—%(12)Sep 2024I/O
Student HousingAL19.519.4S+3.95%9.6%May 2024I/O
Self StoragePA18.218.1S+3.00%8.6%Dec 2025I/O
Self StorageNJ17.617.5S+2.90%9.0%Apr 2025I/O
Self StorageWA11.511.4S+2.90%9.0%Mar 2025I/O
Self StorageIN11.011.0S+3.60%9.0%Jun 2026I/O
IndustrialTX10.010.0S+5.35%11.1%Dec 2024I/O
Self StorageMA7.77.7S+3.00%8.5%Nov 2024I/O
Self StorageMA6.86.7S+3.00%8.5%Oct 2024I/O
IndustrialTN6.46.4S+5.60%11.3%Nov 2024I/O
Self StorageNJ5.95.9S+3.00%8.8%Jul 2024I/O
Subordinated Debt and Preferred
Equity Investments:
MultifamilySC20.620.5S+9.53%15.3%Sep 2025I/O
OfficeNJ18.515.812.00%—%(13)Jan 2026I/O
OfficeNY9.87.65.50%—%(10)Jul 2027(10)I/O
Total/Weighted Average $2,044.9$2,014.57.9%
_________________________

(1)The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 13 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.
(2)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts)
and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on SOFR as of March 31, 2024 or the SOFR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of March 31, 2024 as weighted by the outstanding principal balance of each loan.
(3)Reflects the initial loan maturity date excluding any contractual extension options. Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
(4)I/O = interest only, P/I = principal and interest.
(5)The Illinois loan is structured as both a senior and mezzanine loan with the Company holding both positions. The senior position has a per annum interest rate of S + 2.25% and the mezzanine position has a fixed per annum interest rate of 10.00%. The mezzanine position of this loan, which had an outstanding principal balance of $46.2 million as of March 31, 2024, was on non-accrual status as of March 31, 2024 and therefore, the Unleveraged Effective Yield presented is for the senior position only as the mezzanine position is non-interest accruing. As of March 31, 2024, the borrower is current on all contractual interest payments.
(6)In April 2022, amortization began on the senior North Carolina loan, which had an outstanding principal balance of $68.6 million as of March 31, 2024. In January 2023, amortization began on the senior Georgia loan, which had an outstanding principal balance of $48.4 million as of March 31, 2024. In February 2023, amortization began on the senior diversified loan, which had an outstanding principal balance of $109.0 million as of March 31, 2024. In December 2023, amortization began on the senior California loan, which had an outstanding principal balance of $20.4 million as of March 31, 2024. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
(7)In March 2024, the Company and the borrower entered into a modification agreement to, among other things, reduce the interest rate on the senior Texas loan from S+3.50% to S+3.00%.
(8)The New York loan is structured as both a senior and mezzanine loan with the Company holding both positions. The senior and mezzanine positions each have a per annum interest rate of S + 8.95%. The senior and mezzanine loans were both on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the New York loan from April 2024 to December 2025.
(9)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the senior North Carolina loan from March 2024 to May 2024. For the three months ended March 31, 2024, the Company received $1.7 million of interest payments in cash on the senior North Carolina loan that was recognized as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. See Note 16 included in these consolidated financial statements for a subsequent event related to the senior North Carolina loan.
(10)In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, split the existing senior New York loan, which was on non-accrual status and had an outstanding principal balance of $73.8 million at the time of the modification, into a senior A-Note with an outstanding principal balance of $60.0 million and a subordinated B-Note with an outstanding principal balance of $13.8 million. In conjunction with the modification, the borrower repaid the outstanding principal of the senior A-Note down to $59.0 million and the subordinated B-Note down to $9.8 million. The subordinated B-Note is subordinate to new sponsor equity related to the loan paydown and additional capital contributions. In addition, the maturity date of the senior A-Note and the subordinated B-Note was extended from August 2025 to July 2027. The senior A-Note has a per annum interest rate of S + 2.65% and the subordinated B-Note has a fixed per annum interest rate of 5.50%. During the three months ended March 31, 2024, the senior A-Note, which had an outstanding principal balance of $59.0 million as of March 31, 2024, was restored to accrual status. As of March 31, 2024, the subordinated B-Note, which had an outstanding principal balance of $9.8 million, was on non-accrual status and therefore, the Unleveraged Effective Yield is not applicable. As of March 31, 2024, the borrower is current on all contractual interest payments for the senior A-Note and the subordinated B-Note.
(11)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. As of March 31, 2024, the senior California loan, which is collateralized by an office property, is in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2023 maturity date. The Company is in the process of a foreclosure of the property. Once legal title of the property is acquired, the Company will derecognize the senior California loan and recognize the office property as real estate owned.
(12)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. For the three months ended March 31, 2024, the Company received $454 thousand of interest payments in cash on the senior California loan that was recognized as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments.
(13)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. The mezzanine New Jersey loan is currently in default due to the borrower not making its contractual interest payments due subsequent to the December 2023 interest payment date. For the three months ended March 31, 2024, the Company received $37 thousand of interest payments in cash on the mezzanine New Jersey loan that was recognized as a reduction to the carrying value of the loan.

The Company has made, and may continue to make, modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, asset release prices, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis. The Company’s Manager monitors and evaluates each of the Company’s loans held for investment and is maintaining regular communications with borrowers and sponsors regarding the potential impacts of current macroeconomic conditions on the Company’s loans.

For the three months ended March 31, 2024, the activity in the Company’s loan portfolio was as follows ($ in thousands):
Balance at December 31, 2023$2,126,524 
Initial funding— 
Origination and other loan fees and discounts, net of costs(232)
Additional funding 13,035 
Amortizing payments(3,389)
Loan payoffs (1)(122,685)
Origination and other loan fees and discount accretion 1,247 
Balance at March 31, 2024$2,014,500 
_________________________

(1)    Amount includes the carrying value of certain loans where the carrying value exceeded the net proceeds received from the payoff of the loan. In February 2024, the Company received a discounted payoff on a senior mortgage loan with outstanding principal of $18.8 million, which was collateralized by a multifamily property located in Washington, in conjunction with a short sale of the multifamily property by the borrower to a third party. At the time of the discounted payoff, the senior mortgage loan was in default due to the failure of the borrower to repay the outstanding principal balance of the loan by the September 2023 maturity date. For the three months ended March 31, 2024, the Company recognized a realized loss of $1.7 million in the Company’s consolidated statements of operations as the carrying value of the senior mortgage loan exceeded the net proceeds from the payoff of the loan. In addition, in March 2024, the Company received a discounted payoff on a senior mortgage loan with outstanding principal of $56.9 million, which was collateralized by an office property located in Illinois, in conjunction with a short sale of the office property by the borrower to a third party. At the time of the discounted payoff, the senior mortgage loan was in default due to the failure of the borrower to repay the outstanding principal balance of the loan by the February 2024 maturity date. For the three months ended March 31, 2024, the Company recognized a realized loss of $43.1 million in the Company’s consolidated statements of operations as the carrying value of the senior mortgage loan exceeded the net proceeds from the payoff of the loan.

Except as described in the table above listing the Company’s loans held for investment portfolio, as of March 31, 2024, all loans held for investment were paying in accordance with their contractual terms. As of March 31, 2024, the Company had seven loans held for investment on non-accrual status with a carrying value of $266.5 million. As of December 31, 2023, the Company had nine loans held for investment on non-accrual status with a carrying value of $399.3 million.
v3.24.1.u1
CURRENT EXPECTED CREDIT LOSSES
3 Months Ended
Mar. 31, 2024
Credit Loss [Abstract]  
CURRENT EXPECTED CREDIT LOSSES CURRENT EXPECTED CREDIT LOSSES
The Company estimates its CECL Reserve primarily using a probability-weighted model that considers the likelihood of default and expected loss given default for each individual loan. Calculation of the CECL Reserve requires loan-specific data, which includes capital senior to the Company when the Company is the subordinate lender, changes in net operating income, debt service coverage ratio, loan-to-value, occupancy, property type and geographic location. Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of the Company’s floating rate loan portfolio and (iv) the Company’s current and future view of the macroeconomic environment. The Company may consider loan-specific qualitative factors on certain loans to estimate its CECL Reserve. In order to estimate the future expected loan losses relevant to the Company’s portfolio, the Company utilizes historical market loan loss data licensed from a third party data service. The third party’s loan database includes historical loss data for commercial mortgage-backed securities, or CMBS, issued dating back to 1998, which the Company believes is a reasonably comparable and available data set to its type of loans. The Company utilized macroeconomic data that reflects weak economic growth in the near term given current macroeconomic conditions; however, the actual financial impact on the Company of the current environment is highly uncertain. For periods beyond the reasonable and supportable forecast period, the Company reverts back to historical loss data. Management’s current estimate of expected credit losses as of March 31, 2024 decreased compared to the current estimate of expected credit losses as of December 31, 2023 primarily due to realized losses on two risk rated “5” loans, shorter average remaining loan term and loan repayments during the three months ended March 31, 2024. These factors were partially offset by an increase in the CECL Reserves for risk rated “4” and “5” loans in the portfolio as a result of the impact of the current macroeconomic environment, including high inflation and interest rates, volatility and reduced liquidity in the office sector and other loan-specific factors during the three months ended March 31, 2024. The CECL Reserve also takes into consideration the assumed impact of macroeconomic conditions on CRE properties and is not specific to any loan losses or impairments on the Company’s loans held for investment, unless the Company determines that a specifically identifiable reserve is warranted for a select asset.
    
In certain instances, the Company may identify specific loans to be collateral dependent. The Company considers loans to be collateral dependent if both of the following criteria are met: (i) loan is expected to be substantially repaid through the operation or sale of the underlying collateral, and (ii) the borrower is experiencing financial difficulty. The determination of whether these criteria are met for an individual loan requires the use of significant judgment and can be based on several factors subject to uncertainty.

For such loans that the Company determines that foreclosure of the collateral is probable, the Company estimates the CECL Reserve based on the difference between the fair value of the collateral (less costs to sell the asset if repayment is expected through the sale of the collateral) and the amortized cost basis of the loan as of the measurement date. For collateral dependent loans that the Company determines foreclosure is not probable, the Company applies a practical expedient to estimate the CECL Reserve using the difference between the collateral’s fair value (less costs to sell the asset if repayment is expected through the sale of the collateral) and the amortized cost basis of the loan. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral, including methods such as the income approach, the market approach or the direct capitalization approach. These methods require the use of key unobservable inputs, which are inherently uncertain and subjective. Determining the appropriate valuation method and selecting the appropriate key unobservable inputs and assumptions requires significant judgment and consideration of factors specific to the underlying collateral being assessed. Additionally, the key unobservable inputs and assumptions used may vary depending on the information available and market conditions as of the valuation date. As such, the fair value that is used in calculating the CECL Reserve is subject to uncertainty and any actual losses, if incurred, could differ materially from the CECL Reserve.

As of March 31, 2024, the Company’s CECL Reserve for its loans held for investment portfolio is $140.9 million or 658 basis points of the Company’s total loans held for investment commitment balance of $2.1 billion and is bifurcated between the CECL Reserve (contra-asset) related to outstanding balances on loans held for investment of $139.8 million and a liability for unfunded commitments of $1.1 million. The liability was based on the unfunded portion of the loan commitment over the full contractual period over which the Company is exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur, and if funded, the expected credit loss on the funded portion.

As of March 31, 2024, the senior mortgage loan on an office property located in California with a principal balance of $33.2 million and the mezzanine loan on an office property located in New Jersey with a principal balance of $18.5 million both had a risk rating of “5.” As of March 31, 2024, both of these loans were assessed individually and the Company elected to assign CECL Reserves of $14.7 million on the California office loan and $15.9 million on the New Jersey office loan. The CECL Reserves for both of these loans were based on the Company’s estimate of proceeds available from the potential sale of the collateral property less the estimated costs to sell the property and such CECL Reserves are included in the Company’s total CECL Reserve.
Current Expected Credit Loss Reserve for Funded Loan Commitments    

Activity related to the CECL Reserve for outstanding balances on the Company’s loans held for investment as of and for the three months ended March 31, 2024 was as follows ($ in thousands):
Balance at December 31, 2023 (1)
$159,885 
Provision for current expected credit losses(20,122)
Write-offs— 
Recoveries— 
Balance at March 31, 2024 (1)
$139,763 
__________________________

(1)     The CECL Reserve related to outstanding balances on loans held for investment is recorded within current expected credit loss reserve in the Company’s consolidated balance sheets.

Current Expected Credit Loss Reserve for Unfunded Loan Commitments    

Activity related to the CECL Reserve for unfunded commitments on the Company’s loans held for investment as of and for the three months ended March 31, 2024 was as follows ($ in thousands):

Balance at December 31, 2023 (1)
$3,248 
Provision for current expected credit losses(2,147)
Write-offs— 
Recoveries — 
Balance at March 31, 2024 (1)
$1,101 
__________________________

(1)     The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company’s consolidated balance sheets.

The Company continuously evaluates the credit quality of each loan by assessing the risk factors of each loan and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, leasing and tenant profile, projected cash flow, loan structure and exit plan, loan-to-value ratio, debt service coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows:
Ratings    Definition
1Very Low Risk
2Low Risk
3Medium Risk
4High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance
5Impaired/Loss Likely: A loan that has a significantly increased probability of default and principal loss

The risk ratings are primarily based on historical data as well as taking into account future economic conditions.
As of March 31, 2024, the carrying value, excluding the CECL Reserve, of the Company’s loans held for investment within each risk rating by year of origination is as follows ($ in thousands):
20242023202220212020PriorTotal
Risk rating:
1$$$37,800$$$$37,800
2103,75111,446163,85120,320299,368
311,003378,815589,351108,815111,8041,199,788
4185,3487,586153,96484,160431,058
546,48646,486
Total$$114,754$613,409$760,788$262,779$262,770$2,014,500

Accrued Interest Receivable

The Company elected not to measure a CECL Reserve on accrued interest receivable due to the Company’s policy of writing off uncollectible accrued interest receivable balances in a timely manner. As of March 31, 2024 and December 31, 2023, interest receivable of $12.6 million and $13.0 million, respectively, is included within other assets in the Company’s consolidated balance sheets and is excluded from the carrying value of loans held for investment. If the Company were to have uncollectible accrued interest receivable, it generally would reverse accrued and unpaid interest against interest income and no longer accrue for these amounts.
v3.24.1.u1
REAL ESTATE OWNED
3 Months Ended
Mar. 31, 2024
Real Estate Owned [Abstract]  
REAL ESTATE OWNED REAL ESTATE OWNED
On September 8, 2023, the Company acquired legal title to a mixed-use property located in Florida through a consensual foreclosure. Prior to September 8, 2023, the mixed-use property collateralized an $82.9 million senior mortgage loan held by the Company that was in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the February 2023 maturity date. In conjunction with the consensual foreclosure, the Company derecognized the $82.9 million senior mortgage loan and recognized the mixed-use property as real estate owned. As the Company does not expect to complete a sale of the mixed-use property within the next twelve months, the mixed-use property is considered held for use, and is carried at its estimated fair value at acquisition and is presented net of accumulated depreciation or amortization and impairment charges. The Company did not recognize any gain or loss on the derecognition of the senior mortgage loan as the fair value of the mixed-use property of $84.3 million and the net deficit held at the mixed-use property of $1.4 million at acquisition approximated the $82.9 million carrying value of the senior mortgage loan. Certain operating assets and liabilities of the mixed-use property are included within other assets and other liabilities, respectively, in the Company’s consolidated balance sheets and include items such as prepaid expenses, rent receivables, straight-line rent receivables and payables and trade payables.
The following table summarizes the Company’s real estate owned as of March 31, 2024 and December 31, 2023 ($ in thousands):

As of
March 31, 2024December 31, 2023
Land$21,337 $21,337 
Buildings and improvements52,224 52,224 
In-place lease intangibles21,276 21,276 
Above-market lease intangibles547 547 
Below-market lease intangibles(11,084)(11,084)
Total real estate owned84,300 84,300 
Less: Accumulated depreciation and amortization (1,801)(1,016)
Real estate owned, net$82,499 $83,284 

As of March 31, 2024 and December 31, 2023, no impairment charges have been recognized for real estate owned.

For the three months ended March 31, 2024, the Company incurred net depreciation and amortization expense of $786 thousand. With the exception of amortization related to intangible assets and liabilities for above-market or below-market leases, depreciation and amortization expense is included within expenses from real estate owned in the Company’s consolidated statements of operations. Amortization related to intangible assets and liabilities for above-market or below-market leases is recognized as an adjustment to rental revenue and is included within revenue from real estate owned in the Company’s consolidated statements of operations.

Intangible Lease Assets and Liabilities

For the three months ended March 31, 2024, there were no property acquisitions. The weighted average amortization period for the intangible lease assets and liabilities acquired in connection with the Company’s real estate owned during the year ended December 31, 2023 was 9.3 years as of the acquisition date.

The following table summarizes the Company’s intangible lease assets and liabilities that are included within real estate owned as of March 31, 2024 and December 31, 2023 ($ in thousands):

As of March 31, 2024As of December 31, 2023
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Assets:
In-place lease intangibles$21,276 $(1,355)$19,921 $21,276 $(767)$20,509 
Above-market lease intangibles547 (62)485 547 (35)512 
Liabilities:
Below-market lease intangibles(11,084)579 (10,505)(11,084)322 (10,762)

The following table summarizes the amortization of intangible lease assets and liabilities for the three months ended March 31, 2024 ($ in thousands):

Consolidated Statement
of Operations Location
Amount
Assets:
In-place lease intangiblesExpenses from real estate owned$588 
Above-market lease intangiblesRevenue from real estate owned(28)
Liabilities:
Below-market lease intangiblesRevenue from real estate owned257 
The following table summarizes the estimated net amortization schedule for the Company’s intangible lease assets and liabilities that are included within real estate owned as of March 31, 2024 ($ in thousands):

In-PlaceAbove-Market Below-Market
Lease IntangiblesLease IntangiblesLease Intangibles
Remainder of 2024$1,716 $84 $(771)
20252,23291(1,027)
20261,82176(618)
20271,70151(571)
20281,60341(542)
Thereafter10,848142(6,976)
Total$19,921 $485 $(10,505)

Future Minimum Lease Payments

The following table summarizes the future minimum contractual lease payments to be collected by the Company under non-cancelable operating leases, excluding tenant reimbursements of expenses and variable lease payments, as of March 31, 2024 ($ in thousands):

Remainder of 2024$7,521 
202510,106
202610,224
20279,989
20289,976
Thereafter34,332
Total$82,148 
v3.24.1.u1
DEBT
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
Financing Agreements

The Company borrows funds, as applicable in a given period, under the Wells Fargo Facility, the Citibank Facility, the CNB Facility, the MetLife Facility and the Morgan Stanley Facility (individually defined below and collectively, the “Secured Funding Agreements”), Notes Payable (as defined below) and the Secured Term Loan (as defined below). The Company refers to the Secured Funding Agreements, Notes Payable and the Secured Term Loan as the “Financing Agreements.” The outstanding balance of the Financing Agreements in the table below are presented gross of debt issuance costs. As of March 31, 2024 and December 31, 2023, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):
March 31, 2024December 31, 2023
Outstanding BalanceTotal
Commitment
Outstanding BalanceTotal
Commitment
Secured Funding Agreements:
Wells Fargo Facility$216,522 $450,000 (1)$208,540 $450,000 (1)
Citibank Facility204,104 325,000 221,604 325,000 
CNB Facility— 75,000 — 75,000 
MetLife Facility— 180,000 — 180,000 
Morgan Stanley Facility209,673 250,000 209,673 250,000 
Subtotal$630,299 $1,280,000 $639,817 $1,280,000 
Notes Payable $105,000 $105,000 $105,000 $105,000 
Secured Term Loan$150,000 $150,000 $150,000 $150,000 
   Total$885,299 $1,535,000 $894,817 $1,535,000 
______________________________

(1)The maximum commitment for the Wells Fargo Facility (as defined below) may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee.

Some of the Company’s Financing Agreements are collateralized by (i) assignments of specific loans, preferred equity or a pool of loans held for investment or loans held for sale owned by the Company, (ii) interests in the subordinated portion of the Company’s securitization debt, or (iii) interests in wholly-owned entity subsidiaries that hold the Company’s loans held for investment. The Company is the borrower or guarantor under each of the Financing Agreements. Generally, the Company partially offsets interest rate risk by matching the interest index of loans held for investment with the Secured Funding Agreements used to fund them. The Company’s Financing Agreements contain various affirmative and negative covenants, including negative pledges, and provisions regarding events of default that are normal and customary for similar financing arrangements.

Wells Fargo Facility
 
The Company is party to a master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (the “Wells Fargo Facility”), which allows the Company to borrow up to $450.0 million. The maximum commitment may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee. Under the Wells Fargo Facility, the Company is permitted to sell, and later repurchase, certain qualifying senior commercial mortgage loans, A-Notes, pari-passu participations in commercial mortgage loans and mezzanine loans under certain circumstances, subject to available collateral approved by Wells Fargo in its sole discretion. The funding period of the Wells Fargo Facility expires on December 15, 2025. The initial maturity date of the Wells Fargo Facility is December 15, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2027. Advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of one-month SOFR plus a pricing margin range of 1.50% to 3.75%, subject to certain exceptions. See Note 16 included in these consolidated financial statements for a subsequent event related to the Wells Fargo Facility.

Citibank Facility

The Company is party to a $325.0 million master repurchase facility with Citibank, N.A. (“Citibank”) (the “Citibank Facility”). Under the Citibank Facility, the Company is permitted to sell and later repurchase certain qualifying senior commercial mortgage loans and A-Notes approved by Citibank in its sole discretion. The initial maturity date of the Citibank Facility is January 13, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to January 13, 2027. Advances under the Citibank Facility accrue interest at a per annum rate equal to the sum of one-month SOFR plus an indicative pricing margin range of 1.50% to 2.10%, subject to certain exceptions. The Company incurs a non-utilization fee of 25 basis points per annum on the average
daily positive difference between the maximum advances approved by Citibank and the actual advances outstanding on the Citibank Facility. For the three months ended March 31, 2024 and 2023, the Company did not incur a non-utilization fee. See Note 16 included in these consolidated financial statements for a subsequent event related to the Citibank Facility.

CNB Facility
The Company is party to a $75.0 million secured revolving funding facility with City National Bank (the “CNB Facility”). The Company is permitted to borrow funds under the CNB Facility to finance investments and for other working capital and general corporate needs. In January 2024, the Company amended the CNB Facility to, among other things: (1) extend the initial maturity date of the CNB Facility to March 10, 2025, subject to one 12-month extension, which may be exercised at the Company's option if certain conditions described in the CNB Facility are met, including applicable extension fees being paid, which, if exercised, would extend the maturity date to March 10, 2026 and (2) set the interest rate on advances under the CNB Facility to a per annum rate equal to the sum of, at the Company's option, either (a) a SOFR-based rate plus 3.25% or (b) a base rate plus 2.25%, in each case, subject to an interest rate floor. Unless at least 75% of the CNB Facility is used on average, unused commitments under the CNB Facility accrue non-utilization fees at the rate of 0.375% per annum. For the three months ended March 31, 2024 and 2023, the Company incurred a non-utilization fee of $71 thousand and $70 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. See Note 16 included in these consolidated financial statements for a subsequent event related to the CNB Facility.

MetLife Facility    

The Company is party to a $180.0 million revolving master repurchase facility with Metropolitan Life Insurance Company (“MetLife”) (the “MetLife Facility”), pursuant to which the Company may sell, and later repurchase, commercial mortgage loans meeting defined eligibility criteria which are approved by MetLife in its sole discretion. The maturity date of the MetLife Facility is August 13, 2024. Advances under the MetLife Facility accrue interest at a per annum rate equal to the sum of one-month SOFR plus a spread of 2.50%, subject to certain exceptions. Unless at least 65% of the MetLife Facility is utilized, unused commitments under the MetLife Facility accrue non-utilization fees at the rate of 0.25% per annum on the average daily available balance. For the three months ended March 31, 2024 and 2023, the Company incurred a non-utilization fee of $74 thousand and $73 thousand, respectively. The non-utilization fee is included within interest expense in the Company’s consolidated statements of operations. See Note 16 included in these consolidated financial statements for a subsequent event related to the MetLife Facility.
Morgan Stanley Facility
The Company is party to a $250.0 million master repurchase and securities contract with Morgan Stanley Bank, N.A. (“Morgan Stanley”) (the “Morgan Stanley Facility”). Under the Morgan Stanley Facility, the Company is permitted to sell, and later repurchase, certain qualifying commercial mortgage loans collateralized by retail, office, mixed-use, multifamily, industrial, hospitality, student housing or self storage properties. Morgan Stanley may approve the mortgage loans that are subject to the Morgan Stanley Facility in its sole discretion. The initial maturity date of the Morgan Stanley Facility is July 16, 2025, subject to one 12-month extension, which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if exercised, would extend the maturity date of the Morgan Stanley Facility to July 16, 2026. Advances under the Morgan Stanley Facility generally accrue interest at a per annum rate equal to the sum of one-month SOFR plus a spread ranging from 1.75% to 2.25%, determined by Morgan Stanley, depending upon the mortgage loan sold to Morgan Stanley in the applicable transaction. See Note 16 included in these consolidated financial statements for a subsequent event related to the Morgan Stanley Facility.

Notes Payable

ACRC Lender CO LLC, a wholly owned subsidiary of the Company, is party to a Credit and Security Agreement with Capital One, National Association, as administrative agent and collateral agent, and the lender referred to therein. The Credit and Security Agreement provides for a $105.0 million recourse note (the “Notes Payable”). The $105.0 million note is secured by a $133.0 million senior mortgage loan held by the Company on a multifamily property located in New York and is fully and unconditionally guaranteed by the Company pursuant to a Guaranty of Recourse Obligation (the “CapOne Guaranty”). The initial maturity date of the $105.0 million note is July 28, 2025, subject to two 12-month extensions, each of which may be exercised at the Company’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if both were exercised, would extend the maturity date to July 28, 2027. The $105.0 million note accrues interest at a per annum rate equal to the sum of one-month SOFR plus a spread of 2.00%. As of March 31, 2024, the total outstanding principal
balance of the note was $105.0 million. See Note 16 included in these consolidated financial statements for a subsequent event related to the Notes Payable.

Secured Term Loan

The Company and certain of its subsidiaries are party to a $150.0 million Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”). The maturity date of the Secured Term Loan is November 12, 2026. Advances under the Secured Term Loan are subject to the following fixed rates: (i) 4.50% per annum until May 12, 2025, (ii) after May 12, 2025 through November 12, 2025, the interest rate increases 0.125% every three months and (iii) after November 12, 2025 through November 12, 2026, the interest rate increases 0.250% every three months. As of March 31, 2024, the total outstanding principal balance of the Secured Term Loan was $150.0 million.

The total original issue discount on the Secured Term Loan was equal to 0.50% of the commitment amount and represents a discount to the debt cost to be amortized into interest expense using the effective interest method over the term of the Secured Term Loan. For both the three months ended March 31, 2024 and 2023, the per annum effective interest rate of the Secured Term Loan, which is equal to the fixed interest rate plus the accretion of the original issue discount and associated costs, was 4.6%. See Note 16 included in these consolidated financial statements for a subsequent event related to the Secured Term Loan.
v3.24.1.u1
DERIVATIVE FINANCIAL INSTRUMENTS
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS DERIVATIVE FINANCIAL INSTRUMENTS
The Company may use derivative financial instruments, which may include interest rate swaps and interest rate caps, on certain borrowing transactions to manage its net exposure to interest rate changes and to reduce its overall cost of borrowing. These derivatives may or may not qualify as cash flow hedges under the hedge accounting requirements of FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). Derivatives not designated as cash flow hedges are not speculative and are used to manage our exposure to interest rate movements. See Note 2 included in these consolidated financial statements for additional discussion of the accounting for designated and non-designated hedges.

The use of derivative financial instruments involves certain risks, including the risk that the counterparties to these contractual arrangements do not perform as agreed. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties that have appropriate credit ratings and are major financial institutions with which the Company and its affiliates may also have other financial relationships.

As of March 31, 2024 and December 31, 2023, the Company did not have any outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk. In December 2023, the Company's interest rate swap derivative expired and its term was not extended. At the expiration date, the interest rate swap derivative had a notional amount of $30.0 million. Further, in March 2022, the Company re-calibrated its net exposure to interest rate changes by terminating its interest rate cap derivative, which had a notional amount of $170.0 million on the termination date and a strike rate of 0.50%. For the year ended December 31, 2022, the Company recognized a $2.0 million realized gain within OCI in conjunction with the termination of the interest rate cap. In accordance with ASC 815, the realized gain was recognized within current earnings over the remaining original term of the interest rate cap derivative as it was designated as an effective hedge. For the three months ended March 31, 2023, the Company recognized a realized gain of $456 thousand through a reduction in interest expense on the termination of the interest rate cap within current earnings.
v3.24.1.u1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
As further discussed in Note 2 to our consolidated financial statements, the impact of the current macroeconomic conditions on the Company’s business is uncertain. As of March 31, 2024, there were no contingencies recorded on the Company’s consolidated balance sheets as a result of such conditions, however, if global market conditions worsen, it could adversely affect the Company’s business, financial condition and results of operations.

As of March 31, 2024 and December 31, 2023, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):
As of
March 31, 2024December 31, 2023
Total commitments $2,141,364 $2,274,584 
Less: funded commitments (2,044,948)(2,158,045)
Total unfunded commitments $96,416 $116,539 

The Company from time to time may be a party to litigation relating to claims arising in the normal course of business. As of March 31, 2024, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations.
v3.24.1.u1
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Stock Repurchase Program

On July 25, 2023, the Company’s board of directors renewed its stock repurchase program of up to $50.0 million (the “Repurchase Program”), which is expected to be in effect until July 31, 2024, or until the approved dollar amount has been used to repurchase shares. Pursuant to the Repurchase Program, the Company may repurchase shares of its common stock in amounts, at prices and at such times as it deems appropriate, subject to market conditions and other considerations, including all applicable legal requirements. Repurchases may include purchases on the open market or privately negotiated transactions, under Rule 10b5-1 trading plans, under accelerated share repurchase programs, in tender offers and otherwise. The Repurchase Program does not obligate the Company to acquire any particular amount of shares of its common stock and may be modified or suspended at any time at its discretion. During the three months ended March 31, 2024 and 2023, the Company did not repurchase any shares through the Repurchase Program.

Common Stock

There were no shares of the Company’s common stock issued in public or private offerings for the three months ended March 31, 2024 and 2023. See “Equity Incentive Plan” below for shares issued under the Equity Incentive Plan described below.

Equity Incentive Plan
 
On April 23, 2012, the Company adopted an equity incentive plan, which was amended and restated in June 2018 (as further amended, the “Amended and Restated 2012 Equity Incentive Plan”). In February 2022, the Company’s board of directors authorized, and in May 2022, the Company’s stockholders approved, the first amendment to the Amended and Restated 2012 Equity Incentive Plan, which among other things, increased the total number of shares of common stock the Company may grant thereunder to 2,490,000 shares. Pursuant to the Amended and Restated 2012 Equity Incentive Plan, as amended by the first amendment, the Company may grant awards consisting of restricted shares of the Company’s common stock, restricted stock units (“RSUs”) and/or other equity-based awards to the Company’s outside directors, employees of the Manager, officers, ACREM and other eligible awardees under the plan. Any restricted shares of the Company’s common stock and RSUs will be accounted for under FASB ASC Topic 718, Compensation—Stock Compensation, resulting in stock-based compensation expense equal to the grant date fair value of the underlying restricted shares of common stock or RSUs.
 
Restricted stock and RSU grants generally vest ratably over a one to three-year period from the vesting start date. The grantee receives additional compensation for each outstanding restricted stock or RSU grant, classified as dividends paid, equal to the per-share dividends received by the Company’s common stockholders.
The following tables summarize the (i) non-vested shares of restricted stock and RSUs and (ii) vesting schedule of shares of restricted stock and RSUs for the Company’s directors and officers and employees of the Manager as of March 31, 2024:

Schedule of Non-Vested Share and Share Equivalents
 Restricted Stock Grants—DirectorsRSUs—Officers and Employees of the ManagerTotal
Balance at December 31, 202334,215 1,063,366 1,097,581 
Granted — — — 
Vested (16,485)(273,388)(289,873)
Forfeited — (3,750)(3,750)
Balance at March 31, 202417,730 786,228 803,958 

Future Anticipated Vesting Schedule
Restricted Stock Grants—DirectorsRSUs—Officers and Employees of the ManagerTotal
Remainder of 202417,313 5,431 22,744 
2025417 359,885 360,302 
2026— 278,278 278,278 
2027— 142,634 142,634 
2028— — — 
Total 17,730 786,228 803,958 
v3.24.1.u1
EARNINGS PER SHARE
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following information sets forth the computations of basic and diluted earnings per common share for the three months ended March 31, 2024 and 2023 ($ in thousands, except share and per share data):

For the Three Months Ended March 31,
20242023
Net income (loss) attributable to common stockholders$(12,323)$(6,439)
Divided by:
Basic weighted average shares of common stock outstanding:54,396,397 54,591,650 
Weighted average non-vested restricted stock and RSUs (1)— — 
Diluted weighted average shares of common stock outstanding:54,396,397 54,591,650 
Basic earnings (loss) per common share$(0.23)$(0.12)
Diluted earnings (loss) per common share$(0.23)$(0.12)
_______________________________
(1)    For the three months ended March 31, 2024 and 2023, the weighted average non-vested restricted stock and RSUs of 813,763 and 682,620 shares, respectively, were excluded from the computation of diluted earnings (loss) per common share as the impact of including those shares would be anti-dilutive.
v3.24.1.u1
INCOME TAX
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAX INCOME TAX
    
The Company wholly owns ACRC Lender W TRS LLC, which is a taxable REIT subsidiary (“TRS”) formed to issue and hold certain loans intended for sale. The Company also wholly owns ACRC 2017-FL3 TRS LLC, which is a TRS formed to hold a portion of the FL3 CLO Securitization and FL4 CLO Securitization (as defined below), including the portion that generates excess inclusion income. Additionally, the Company wholly owns ACRC WM Tenant LLC, which is a TRS formed to lease from an affiliate the hotel property classified as real estate owned acquired on March 8, 2019. ACRC WM Tenant LLC engaged a third-party hotel management company to operate the hotel under a management contract prior to the sale of the hotel on March 1, 2022.

The income tax provision for the Company and the TRSs consisted of the following for the three months ended March 31, 2024 and 2023 ($ in thousands):
For the Three Months Ended March 31,
20242023
Current $— $10 
Deferred — 
Excise tax — 100 
   Total income tax expense, including excise tax$$110 

For the three months ended March 31, 2024, the Company did not incur any expense for U.S. federal excise tax. For the three months ended March 31, 2023, the Company incurred an expense of $100 thousand for U.S. federal excise tax. Excise tax represents a 4% tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the calendar year (including any distribution declared in the fourth quarter and paid following January) plus any prior year shortfall. If it is determined that an excise tax liability exists for the current tax year, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The quarterly expense is calculated in accordance with applicable tax regulations.

The TRSs recognize interest and penalties related to unrecognized tax benefits within income tax expense in the Company’s consolidated statements of operations. Accrued interest and penalties, if any, are included within other liabilities in the Company’s consolidated balance sheets.

As of March 31, 2024, tax years 2019 through 2024 remain subject to examination by taxing authorities. The Company does not have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months.
v3.24.1.u1
FAIR VALUE
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
The Company follows FASB ASC Topic 820-10, Fair Value Measurement (“ASC 820-10”), which expands the application of fair value accounting. ASC 820-10 defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosure requirements for fair value measurements. ASC 820-10 determines fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. ASC 820-10 specifies a hierarchy of valuation techniques based on the inputs used in measuring fair value.

In accordance with ASC 820-10, the inputs used to measure fair value are summarized in the three broad levels listed below:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level 3—Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
GAAP requires disclosure of fair value information about financial and nonfinancial assets and liabilities, whether or not recognized in the financial statements, for which it is practical to estimate the value. In cases where quoted market prices are not available, fair values are based upon the application of discount rates to estimated future cash flows using market yields, or other valuation methodologies. Any changes to the valuation methodology will be reviewed by the Company’s management to ensure the changes are appropriate. The methods used may produce a fair value calculation that is not indicative of net realizable value or reflective of future fair values. Furthermore, while the Company anticipates that the valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial and nonfinancial assets and liabilities could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may fall within periods of market dislocation, during which price transparency may be reduced.

Recurring Fair Value Measurements

Loans Held for Sale

As of March 31, 2024, the Company did not have any loans held for sale. As of December 31, 2023, the Company had one loan held for sale. Loans held for sale are required to be recorded at fair value on a recurring basis in accordance with GAAP. The Company determined the fair value of the one loan held for sale as of December 31, 2023 based on the anticipated transaction price to be received from the third party that was expected to purchase the loan. In January 2024, the Company closed the sale of the loan at a price equal to the fair value as of December 31, 2023.

Available-for-Sale Debt Securities

The Company designates investments in CRE debt securities as available-for-sale on the acquisition date of such CRE debt securities. The Company is required to record investments in available-for-sale debt securities at fair value on a recurring basis in accordance with GAAP. During the year ended December 31, 2022, the Company acquired three CRE debt securities for an aggregate purchase price of $27.9 million, which consisted of floating rate, investment grade rated debt securities that had a weighted average coupon of SOFR plus 2.47%. The Company’s available-for-sale debt securities have a contractual maturity greater than 10 years from the purchase date.

As of both March 31, 2024 and December 31, 2023, the Company had three CRE debt security investments designated as available-for-sale debt securities. The following tables summarize the Company’s investments in available-for-sale debt securities as of March 31, 2024 and December 31, 2023 ($ in thousands):

As of March 31, 2024
Face AmountAmortized CostUnamortized DiscountUnrealized Gain (Loss), Net
Available-for-sale debt securities$28,000 $27,913 $87 $235 


As of December 31, 2023
Face AmountAmortized CostUnamortized DiscountUnrealized Gain (Loss), Net
Available-for-sale debt securities$28,000 $27,906 $94 $154 


The fair value of available-for-sale debt securities was estimated using third-party broker quotes, which provide valuation estimates based upon contractual cash flows, observable inputs comprising credit spreads and market liquidity.

The following tables summarize the financial assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 ($ in thousands):
As of March 31, 2024
Level 1Level 2Level 3Total
Financial assets:
Available-for-sale debt securities$— $28,148 $— $28,148 
As of December 31, 2023
Level 1Level 2Level 3Total
Financial assets:
Loans held for sale$— $— $38,981 $38,981 
Available-for-sale debt securities— 28,060 — 28,060 

As of March 31, 2024 and December 31, 2023, the Company did not have any financial liabilities or nonfinancial assets or liabilities required to be recorded at fair value on a recurring basis.
Nonrecurring Fair Value Measurements

The Company is required to record real estate owned, a nonfinancial asset, at fair value on a nonrecurring basis in accordance with GAAP. Real estate owned consists of a mixed-use property that was acquired by the Company on September 8, 2023 through a consensual foreclosure. See Note 5 included in these consolidated financial statements for more information on real estate owned. Real estate owned is recorded at fair value at acquisition using Level 3 inputs and is evaluated for indicators of impairment on a quarterly basis. Real estate owned is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate owned over the estimated remaining holding period is less than the carrying amount of such real estate owned. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate owned. An impairment charge is recorded equal to the excess of the carrying value of the real estate owned over the fair value. The fair value of the mixed-use property at acquisition was estimated using a third-party appraisal, which utilized standard industry valuation techniques such as the income and market approach. When determining the fair value of the mixed-use property, certain assumptions are made including, but not limited to: (1) projected operating cash flows, including factors such as property operating expenses and re-leasing assumptions that take into account the number of months to re-lease, market rental revenue and required tenant improvements; and (2) projected cash flows from the eventual disposition of the mixed-use property based upon the Company’s estimation of a capitalization rate, discount rates and comparable selling prices in the market. The fair value of the mixed-use property was estimated using significant unobservable inputs such as capitalization rates ranging from 6.4% to 8.3% and discount rates ranging from 8.0% to 9.5%.

As of March 31, 2024 and December 31, 2023, the Company did not have any financial assets or liabilities or nonfinancial liabilities required to be recorded at fair value on a nonrecurring basis.

Financial Assets and Liabilities Not Measured at Fair Value
 
As of March 31, 2024 and December 31, 2023, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):
As of
March 31, 2024December 31, 2023
Level in Fair Value HierarchyCarrying ValueFair
Value
Carrying ValueFair
Value
Financial assets:
   Loans held for investment3$2,014,500 $1,870,433 $2,126,524 $1,944,718 
Financial liabilities:
   Secured funding agreements2$630,299 $630,299 $639,817 $639,817 
   Notes payable 2104,714 105,000 104,662 105,000 
   Secured term loan3149,443 135,372 149,393 134,024 
Collateralized loan obligation securitization debt (consolidated VIEs)2595,105 586,195 723,117 705,033 

The carrying values of cash and cash equivalents, restricted cash, interest receivable, due to affiliate liability and accrued expenses, which are all categorized as Level 2 within the fair value hierarchy, approximate their fair values due to their short-term nature.
 
Loans held for investment are recorded at cost, net of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds. To determine the fair value of the collateral, the Company may employ different approaches depending on the type of collateral. The Company determined the fair value of loans held for investment based on a discounted cash flow methodology (1) for risk rated “1”, “2”, or “3” loans, on a portfolio basis and (b) for risk rated “4” or “5” loans, on an asset-by-asset basis, in each case taking into consideration various factors including capitalization rates, discount rates, leasing, occupancy rates, availability and cost of financing, exit plan, sponsorship, actions of other lenders, and comparable selling prices in the market. The Secured Funding Agreements and Notes Payable are recorded at outstanding principal, which is the Company’s best estimate of the fair value. The Company determined the fair value of the Secured Term Loan and collateralized loan obligation (“CLO”) securitization debt based on a discounted cash flow methodology, taking into consideration various factors including discount rates, actions of other lenders and comparable market quotes and recent trades for similar products.
v3.24.1.u1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
Management Agreement

The Company is party to an Amended and Restated Management Agreement under which ACREM, subject to the supervision and oversight of the Company’s board of directors, is responsible for, among other duties, (a) performing all of the Company’s day-to-day functions, (b) determining the Company’s investment strategy and guidelines in conjunction with the Company’s board of directors, (c) sourcing, analyzing and executing investments, asset sales and financing, and (d) performing portfolio management duties. In addition, ACREM has an Investment Committee that oversees compliance with the Company’s investment strategy and guidelines, loans held for investment portfolio holdings and financing strategy.

In exchange for its services, ACREM is entitled to receive a base management fee, an incentive fee and expense reimbursements. In addition, ACREM and its personnel may receive grants of equity-based awards pursuant to the Company’s Amended and Restated 2012 Equity Incentive Plan and a termination fee, if applicable.
 
The base management fee is equal to 1.5% of the Company’s stockholders’ equity per annum, which is calculated and payable quarterly in arrears in cash. For purposes of calculating the base management fee, stockholders’ equity means: (a) the sum of (i) the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro-rata daily basis for such issuances during the fiscal quarter of any such issuance), plus (ii) the Company’s retained earnings at the end of the most recently completed fiscal quarter determined in accordance with GAAP (without taking into account any non-cash equity compensation expense incurred in current or prior periods); less (b) (x) any amount that the Company has paid to repurchase the Company’s common stock since inception, (y) any unrealized gains and losses and other non-cash items that have impacted stockholders’ equity as reported in the Company’s consolidated financial statements prepared in accordance with GAAP, and (z) one-time events pursuant to changes in GAAP, and certain non-cash items not otherwise described above, in each case after discussions between ACREM and the Company’s independent directors and approval by a majority of the Company’s independent directors. As a result, the Company’s stockholders’ equity, for purposes of calculating the management fee, could be greater or less than the amount of stockholders’ equity shown in the Company’s consolidated financial statements.
 
The incentive fee is an amount, not less than zero, equal to the difference between: (a) the product of (i) 20% and (ii) the difference between (A) the Company’s Core Earnings (as defined below) for the previous 12-month period, and (B) the product of (1) the weighted average of the issue price per share of the Company’s common stock of all of the Company’s public offerings of common stock multiplied by the weighted average number of all shares of common stock outstanding including any restricted shares of the Company’s common stock, RSUs, or any shares of the Company’s common stock not yet issued, but underlying other awards granted under the Company’s Amended and Restated 2012 Equity Incentive Plan (see Note 9 included in these consolidated financial statements) in the previous 12-month period, and (2) 8%; and (b) the sum of any incentive fees earned by ACREM with respect to the first three fiscal quarters of such previous 12-month period; provided, however, that no incentive fee is payable with respect to any fiscal quarter unless cumulative Core Earnings for the 12 most recently completed fiscal quarters is greater than zero. “Core Earnings” is defined in the Management Agreement as net income (loss) computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fee, depreciation and amortization (to the extent that any of the Company’s target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), and one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between ACREM and the Company’s independent directors and after approval by a majority of the Company’s independent directors. Core Earnings is defined in the Management Agreement and is used to calculate the incentive fees the Company pays to ACREM. For the three months ended March 31, 2024 and 2023, the Company did not incur any incentive fees.
The Company reimburses ACREM at cost for operating expenses that ACREM incurs on the Company’s behalf, including expenses relating to legal, financial, accounting, servicing, due diligence and other services, expenses in connection with the origination and financing of the Company’s investments, communications with the Company’s stockholders, information technology systems, software and data services used for the Company, travel, complying with legal and regulatory requirements, taxes, insurance maintained for the benefit of the Company as well as all other expenses actually incurred by ACREM that are reasonably necessary for the performance by ACREM of its duties and functions under the Management Agreement. Ares Management, from time to time, incurs fees, costs and expenses on behalf of more than one investment vehicle. To the extent such fees, costs and expenses are incurred for the account or benefit of more than one fund, each such investment vehicle, including the Company, will typically bear an allocable portion of any such fees, costs and expenses in proportion to the size of its investment in the activity or entity to which such expense relates (subject to the terms of each fund’s governing documents) or in such other manner as Ares Management considers fair and equitable under the circumstances, such as the relative fund size or capital available to be invested by such investment vehicles. Where an investment vehicle’s governing documents do not permit the payment of a particular expense, Ares Management will generally pay such investment vehicle’s allocable portion of such expense. In addition, the Company is responsible for its proportionate share of certain fees and expenses, including due diligence costs, as determined by ACREM and Ares Management, including legal, accounting and financial advisor fees and related costs, incurred in connection with evaluating and consummating investment opportunities, regardless of whether such transactions are ultimately consummated by the parties thereto.
 
The Company will not reimburse ACREM for the salaries and other compensation of its personnel, except for the allocable share of the salaries and other compensation of the Company’s (a) Chief Financial Officer, based on the percentage of his time spent on the Company’s affairs and (b) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of ACREM or its affiliates who spend all or a portion of their time managing the Company’s affairs based on the percentage of their time spent on the Company’s affairs. The Company is also required to pay its pro-rata portion of rent, telephone, utilities, office furniture, equipment, machinery and other office, internal and overhead expenses of ACREM and its affiliates that are required for the Company’s operations.
 
Certain of the Company’s subsidiaries, along with the Company’s lenders under certain of the Company’s Secured Funding Agreements, as well as under the CLO transaction have entered into various servicing agreements with ACREM’s subsidiary servicer, Ares Commercial Real Estate Servicer LLC (“ACRES”). The Company’s Manager will specially service, as needed, certain of the Company’s investments. Effective May 1, 2012, ACRES agreed that no servicing fees pursuant to these servicing agreements would be charged to the Company or its subsidiaries by ACRES or the Manager for so long as the Management Agreement remains in effect, but that ACRES will continue to receive reimbursement for overhead related to servicing and operational activities pursuant to the terms of the Management Agreement.

The term of the Management Agreement ends on April 25, 2025, with automatic one-year renewal terms thereafter. Except under limited circumstances, upon a termination of the Management Agreement, the Company will pay ACREM a termination fee equal to three times the average annual base management fee and incentive fee received by ACREM during the 24-month period immediately preceding the most recently completed fiscal quarter prior to the date of termination, each as described above.

The following table summarizes the related party costs incurred by the Company for the three months ended March 31, 2024 and 2023, and amounts payable to the Company’s Manager as of March 31, 2024 and December 31, 2023 ($ in thousands):
IncurredPayable
For the Three Months Ended March 31,As of
20242023March 31, 2024December 31, 2023
Affiliate Payments
Management fees $2,768 $3,010 $2,768 $2,946 
Incentive fees— — — — 
General and administrative expenses 1,132 732 1,458 1,154 
Direct costs (1)44 20 55 35 
   Total$3,944 $3,762 $4,281 $4,135 
_______________________________

(1)    For the three months ended March 31, 2024 and 2023, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.
Investments in Loans

From time to time, the Company may co-invest with other investment vehicles managed by Ares Management or its affiliates, including the Manager, and their portfolio companies, including by means of splitting investments, participating in investments or other means of syndication of investments. For such co-investments, the Company expects to act as the administrative agent for the holders of such investments provided that the Company maintains a majority of the aggregate investment. No fees will be received by the Company for performing such service. The Company will be responsible for its pro-rata share of costs and expenses for such co-investments, including due diligence costs for transactions which fail to close. The Company’s investment in such co-investments are made on a pari-passu basis with the other Ares managed investment vehicles and the Company is not obligated to provide, nor has it provided, any financial support to the other Ares managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment and the Company recognizes only the carrying value of its investment in its consolidated balance sheets. As of March 31, 2024 and December 31, 2023, the total outstanding principal balance for co-investments held by the Company was $241.5 million and $236.7 million, respectively.
Loan Purchases From Affiliate

One or more affiliates of the Company’s Manager may originate commercial real estate loans, which may be made available for purchase by other investment vehicles, including the Company and other Ares Management managed investment vehicles. From time to time, the Company may purchase such commercial real estate loans from affiliates of the Company’s Manager. The Company’s Manager will approve the purchase of such loans only on terms, including the consideration to be paid, that are determined by the Company’s Manager in good faith to be appropriate for the Company and provided that the Company has sufficient liquidity. The Company is not obligated to purchase any loans originated by affiliates of the Company’s Manager. In addition, from time to time, the Company may purchase loans, including participations in loans, from other Ares Management managed investment vehicles. Loans purchased by the Company from affiliates of the Company’s Manager or other Ares Management managed investment vehicles are purchased at fair value as determined by an independent third-party valuation expert and are subject to approval by a majority of the Company’s independent directors. No loans were purchased by the Company from affiliates of the Company’s Manager or other Ares Management managed investment vehicles for the three months ended March 31, 2024 and 2023.
v3.24.1.u1
DIVIDENDS AND DISTRIBUTIONS
3 Months Ended
Mar. 31, 2024
DIVIDENDS AND DISTRIBUTIONS  
DIVIDENDS AND DISTRIBUTIONS DIVIDENDS AND DISTRIBUTIONS
The following table summarizes the Company’s dividends declared during the three months ended March 31, 2024 and 2023 ($ in thousands, except per share data):

Date DeclaredRecord DatePayment DatePer Share AmountTotal Amount
February 22, 2024March 28, 2024April 16, 2024$0.25 $13,802 
Total cash dividends declared for the three months ended March 31, 2024$0.25 $13,802 
February 15, 2023March 31, 2023April 18, 2023$0.35 (1)$19,345 
Total cash dividends declared for the three months ended March 31, 2023$0.35 $19,345 
_______________________________
(1)     Consists of a regular cash dividend of $0.33 and a supplemental cash dividend of $0.02.
v3.24.1.u1
VARIABLE INTEREST ENTITIES
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VARIABLE INTEREST ENTITIES VARIABLE INTEREST ENTITIES
Consolidated VIEs

As discussed in Note 2, the Company evaluates all of its investments and other interests in entities for consolidation, including its investments in the CLO Securitizations (as defined below), which are considered to be variable interests in VIEs.

CLO Securitizations

On January 11, 2019, ACRE Commercial Mortgage 2017-FL3 Ltd. (the “FL3 Issuer”) and ACRE Commercial Mortgage 2017-FL3 LLC (the “FL3 Co-Issuer”), both wholly-owned indirect subsidiaries of the Company, entered into an Amended and Restated Indenture (the “FL3 Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the approximately $504.1 million principal balance of secured floating rate notes (the “FL3 Notes”) issued by the FL3 Issuer and $52.9 million of preferred equity in the FL3 Issuer (the “FL3 CLO Securitization”). The FL3 Amended Indenture amends and restates, and replaces in its entirety, the indenture for the CLO securitization issued in March 2017, which governed the issuance of approximately $308.8 million principal balance of secured floating rate notes and $32.4 million of preferred equity in the FL3 Issuer.

As of March 31, 2024, the FL3 Notes were collateralized by interests in a pool of 15 mortgage assets having a total principal balance of $469.2 million (the “FL3 Mortgage Assets”) that were closed by a wholly-owned subsidiary of the Company and $6.5 million of receivables related to repayments of outstanding principal on previous mortgage assets. As of December 31, 2023, the FL3 Notes were collateralized by interests in a pool of 16 mortgage assets having a total principal balance of $526.0 million that were closed by a wholly-owned subsidiary of the Company and $31.0 million of receivables related to repayments of outstanding principal on previous mortgage assets. On April 13, 2021, the FL3 Issuer and the FL3 Co-Issuer entered into a First Supplement to Amended and Restated Indenture (the “2021 Amended Indenture”) with Wells Fargo Bank, National Association, as advancing agent and note administrator, and Wilmington Trust, National Association, as trustee, which governs the FL3 CLO Securitization. The purpose of the 2021 Amended Indenture was to, among other things, extend the reinvestment period to March 31, 2024. During the reinvestment period, the Company was able to direct the FL3 Issuer to acquire additional mortgage assets subject to certain conditions. The reinvestment period expired on March 31, 2024 and was not renewed.
 
The contribution of the FL3 Mortgage Assets to the FL3 Issuer is governed by a Mortgage Asset Purchase Agreement between ACRC Lender LLC, a wholly owned subsidiary of the Company (the “Seller”) and the FL3 Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants.
 
In connection with the securitization, the FL3 Issuer and FL3 Co-Issuer offered and issued the following classes of Notes: Class A, Class A-S, Class B, Class C and Class D Notes (collectively, the “FL3 Offered Notes”) to a third party. The Company retained (through one of its wholly-owned subsidiaries) approximately $58.5 million of the FL3 Notes and all of the $52.9 million of preferred equity in the FL3 Issuer, which totaled $111.4 million. The Company, as the holder of the subordinated FL3 Notes and all of the preferred equity in the FL3 Issuer, has the obligation to absorb losses of the CLO, since the Company has a first loss position in the capital structure of the CLO. During the three months ended March 31, 2024, the Company paid down $31.2 million of the FL3 Offered Notes. During the three months ended March 31, 2023, the Company did not pay down any of the FL3 Offered Notes.

On January 28, 2021, ACRE Commercial Mortgage 2021-FL4 Ltd. (the “FL4 Issuer”) and ACRE Commercial Mortgage 2021-FL4 LLC (the “FL4 Co-Issuer”), both wholly owned indirect subsidiaries of the Company, entered into an Indenture (the “FL4 Indenture”) with the Seller, as advancing agent, Wells Fargo Bank, National Association, as note administrator, and Wilmington Trust, National Association, as trustee, which governs the issuance of approximately $603.0 million principal balance secured floating rate notes (the “FL4 Notes”) and $64.3 million of preferred equity in the FL4 Issuer (the “FL4 CLO Securitization”). For U.S. federal income tax purposes, the FL4 Issuer and FL4 Co-Issuer are disregarded entities.

As of March 31, 2024, the FL4 Notes were collateralized by interests in a pool of six mortgage assets having a total principal balance of $304.7 million (the “FL4 Mortgage Assets”) that were closed by a wholly-owned subsidiary of the Company. As of December 31, 2023, the FL4 Notes were collateralized by interests in a pool of nine mortgage assets having a total principal balance of $404.1 million that were closed by a wholly-owned subsidiary of the Company and $1.0 million of receivables related to repayments of outstanding principal on previous mortgage assets. During the period ending in April 2024
(the “Companion Participation Acquisition Period”), the FL4 Issuer may use certain principal proceeds from the FL4 Mortgage Assets to acquire additional funded pari-passu participations related to the FL4 Mortgage Assets that meet certain acquisition criteria.

The sale of the FL4 Mortgage Assets to the FL4 Issuer is governed by a FL4 Mortgage Asset Purchase Agreement between the Seller and the FL4 Issuer, and acknowledged by the Company solely for purposes of confirming its status as a REIT, in which the Seller made certain customary representations, warranties and covenants.

In connection with the FL4 CLO Securitization, the FL4 Issuer and FL4 Co-Issuer offered and issued the following classes of FL4 Notes to third party investors: Class A, Class A-S, Class B, Class C, Class D and Class E Notes (collectively, the “FL4 Offered Notes”). A wholly owned subsidiary of the Company retained approximately $62.5 million of the FL4 Notes and all of the $64.3 million of preferred equity in the FL4 Issuer, which totaled $126.8 million. The Company, as the holder of the subordinated FL4 Notes and all of the preferred equity in the FL4 Issuer, has the obligation to absorb losses of the FL4 CLO Securitization, since the Company has a first loss position in the capital structure of the FL4 CLO Securitization. During the three months ended March 31, 2024 and 2023, the Company paid down $97.1 million and $42.1 million of the FL4 Offered Notes, respectively.
 
The FL3 CLO Securitization and the FL4 CLO Securitization are collectively referred to as the “CLO Securitizations.” As the directing holder of the CLO Securitizations, the Company has the ability to direct activities that could significantly impact the CLO Securitizations’ economic performance. ACRES is designated as special servicer of the CLO Securitizations and has the power to direct activities during the loan workout process on defaulted and delinquent loans, which is the activity that most significantly impacts the CLO Securitizations’ economic performance. ACRES did not waive the special servicing fee, and the Company pays its overhead costs. If an unrelated third party had the right to unilaterally remove the special servicer, then the Company would not have the power to direct activities that most significantly impact the CLO Securitizations’ economic performance. In addition, there were no substantive kick-out rights of any unrelated third party to remove the special servicer without cause. The Company’s subsidiaries, as directing holders, have the ability to remove the special servicer without cause. Based on these factors, the Company is determined to be the primary beneficiary of each of the CLO Securitizations; thus, the CLO Securitizations are consolidated into the Company’s consolidated financial statements.

The CLO Securitizations are consolidated in accordance with FASB ASC Topic 810 and are structured as pass through entities that receive principal and interest on the underlying collateral and distributes those payments to the note holders, as applicable. The assets and other instruments held by the CLO Securitizations are restricted and can only be used to fulfill the obligations of the respective CLO Securitizations. Additionally, the obligations of the CLO Securitizations do not have any recourse to the general credit of any other consolidated entities, nor to the Company as the primary beneficiary.

The inclusion of the assets and liabilities of the CLO Securitizations of which the Company is deemed the primary beneficiary has no economic effect on the Company. The Company’s exposure to the obligations of the CLO Securitizations are generally limited to its investment in the entity. The Company is not obligated to provide, nor has it provided, any financial support for the consolidated structures. As such, the risk associated with the Company’s involvement in the CLO Securitizations are limited to the carrying value of its investment in each of the entities. As of March 31, 2024, the Company’s maximum risk of loss was $184.8 million, which represents the carrying value of its investments in the CLO Securitizations.

Non-consolidated VIEs

The Company evaluated its senior mortgage loan investment that is collateralized by a residential condominium property located in New York, and it was determined to be an interest in a VIE. However, the Company was not deemed to be the primary beneficiary. The Company’s exposure to the obligations of the VIE is generally limited to its investment and the Company is not obligated to provide, nor has it provided, any financial support to the VIE. As such, the risk associated with the Company’s involvement in the VIE is limited to the carrying value of its investment. As of March 31, 2024, the Company’s maximum risk of loss was $88.3 million, which represents the carrying value of its investment in the VIE.
v3.24.1.u1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
The Company’s management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this quarterly report on Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the three months ended March 31, 2024, except as disclosed below.

The Company’s board of directors declared a regular cash dividend of $0.25 per common share for the second quarter of 2024. The second quarter 2024 dividend will be payable on July 16, 2024 to common stockholders of record as of June 28, 2024.

On April 19, 2024, April 23, 2024, April 26, 2024 and May 6, 2024, the Company entered into amendments to each of the Wells Fargo Facility, the Citibank Facility, the CNB Facility and Morgan Stanley Facility, respectively, to, among other things, clarify the calculation of tangible net worth of the Company.

In May 2024, the senior mortgage loan held by the Company on an office property located in North Carolina was not repaid upon its contractual maturity, which triggered an event of default under the loan agreement. As of May 7, 2024, the outstanding principal balance of the senior North Carolina loan is $68.6 million.

On May 6, 2024, the Company entered into an amendment to the CapOne Guaranty. The purpose of the amendment was to, among other things, clarify the calculation of tangible net worth of the Company and limit the amount of CECL Reserves permitted to be added to stockholders’ equity for purposes of calculating the tangible net worth of the Company.

On May 8, 2024, the Company, as borrower, and ACRC Holdings LLC, ACRC Mezz Holdings LLC and ACRC Warehouse Holdings LLC, wholly-owned subsidiaries of the Company, as guarantors, entered into an amendment to the Secured Term Loan. The purpose of the amendment was to, among other things, (i) change the schedule of interest rate increases, (ii) add contingent interest rate increases based on the outstanding principal amount of the Secured Term Loan on specific dates and the tangible net worth of the Company, and (iii) make changes to financial covenants, including reducing the minimum tangible net worth requirement and linking future determinations thereof to the outstanding principal amount of the Secured Term Loan, increasing the minimum unencumbered asset ratio requirement, reducing the maximum total net leverage ratio and increasing the senior loan concentration threshold. In connection with the amendment and concurrently therewith, the Company paid a modification fee and paid down $10 million of principal of the Secured Term Loan which reduced the outstanding principal balance of the loan from $150 million to $140 million.
v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Pay vs Performance Disclosure          
Net income (loss) attributable to common stockholders $ (12,323) $ (39,414) $ 9,184 $ (2,198) $ (6,439)
v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying unaudited consolidated interim financial statements have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and include the accounts of the Company, the consolidated variable interest entities (“VIEs”) that the Company controls and of which the Company is the primary beneficiary, and the Company’s wholly-owned subsidiaries. The unaudited consolidated interim financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the Company’s results of operations and financial condition as of and for the periods presented. All intercompany balances and transactions have been eliminated.

The unaudited consolidated interim financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The current period’s results of operations will not necessarily be indicative of results for any other interim period or that ultimately may be achieved for the year ending December 31, 2024.
Use of Estimates in the Preparation of Financial Statements
Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Global macroeconomic conditions, including high inflation, changes to fiscal and monetary policy, high interest rates, potential market-wide liquidity problems, currency fluctuations, labor shortages and challenges in the supply chain, have the potential to negatively impact the Company and its borrowers. These current macroeconomic conditions may continue or aggravate and could cause the United States economy or other global economies to experience an economic slowdown or recession. We anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States or other major global economy.

The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2024, however, uncertainty over the global economy and the Company’s business, makes any estimates and assumptions as of March 31, 2024 inherently less certain than they would be absent the current and potential impacts of current macroeconomic conditions. Actual results could differ from those estimates.
Variable Interest Entities
Variable Interest Entities

The Company evaluates all of its interests in VIEs for consolidation. When the Company’s interests are determined to be variable interests, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The primary beneficiary of a VIE is required to consolidate the VIE. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, defines the primary beneficiary as the party that has both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant. The Company considers its variable interests, as well as any variable interests of its related parties in making this determination. Where both of these factors are present, the Company is deemed to be the primary beneficiary and it consolidates the VIE. Where either one of these factors is not present, the Company is not the primary beneficiary and it does not consolidate the VIE.
 
To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE or have the right to unilaterally remove those decision makers are deemed to have the power to direct the activities of a VIE.

To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Company considers all of its economic interests, including debt and equity investments, servicing fees, and other arrangements deemed to be variable interests in the VIE. This assessment requires that the Company applies judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Company.

For VIEs of which the Company is determined to be the primary beneficiary, all of the underlying assets, liabilities, equity, revenue and expenses of the structures are consolidated into the Company’s consolidated financial statements.

The Company performs an ongoing reassessment of: (1) whether any entities previously evaluated under the majority voting interest framework have become VIEs, based on certain events, and therefore are subject to the VIE consolidation framework, and (2) whether changes in the facts and circumstances regarding its involvement with a VIE cause the Company’s consolidation conclusion regarding the VIE to change. See Note 15 included in these consolidated financial statements for further discussion of the Company’s VIEs.
Cash and Cash Equivalents
Cash and Cash Equivalents

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short‑term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and statements of cash flows.
Loans Held for Investment
Loans Held for Investment

The Company originates CRE debt and related instruments generally to be held for investment. Loans that are held for investment are carried at cost, net of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds (the “carrying value”). Loans are generally collateralized by real estate. The extent of any credit deterioration associated with the performance and/or value of the underlying collateral property and the financial and operating capability of the borrower could impact the expected amounts received. The Company monitors performance of its loans held for investment portfolio under the following methodology: (1) borrower review, which analyzes the borrower’s ability to execute on its original business plan, reviews its financial condition, assesses pending litigation and considers its general level of responsiveness and cooperation; (2) economic review, which considers underlying collateral (i.e. leasing performance, unit sales and cash flow of the collateral and its ability to cover debt service, as well as the residual loan balance at maturity); (3) property review, which considers current environmental risks, changes in insurance costs or coverage, current site visibility, capital expenditures and market perception; and (4) market review, which analyzes the collateral from a supply and demand perspective of similar property types, as well as from a capital markets perspective. Such analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, and the borrower’s exit plan, among other factors.

Loans are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to reduce loan carrying value depending upon management’s judgment regarding the borrower’s ability to make pending principal and interest payments. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current. The Company may make exceptions to placing a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Loan balances that are deemed to be uncollectible are written off as a realized loss and are deducted from the current expected credit loss reserve. The write-offs are recorded in the period in which the loan balance is deemed uncollectible based on management’s judgment.
Current Expected Credit Losses
Current Expected Credit Losses
FASB ASC Topic 326, Financial Instruments—Credit Losses (“ASC 326”), requires the Company to reflect current expected credit losses (“CECL”) on both the outstanding balances and unfunded commitments on loans held for investment and requires consideration of a broad range of historical experience adjusted for current conditions and reasonable and supportable forecast information to inform credit loss estimates (the “CECL Reserve” or “CECL Reserves”). Increases and decreases to expected credit losses impact earnings and are recorded within provision for current expected credit losses in the Company’s consolidated statements of operations. The CECL Reserve related to outstanding balances on loans held for investment required under ASC 326 is a valuation account that is deducted from the amortized cost basis of the Company’s loans held for investment in the Company’s consolidated balance sheets. The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company’s consolidated balance sheets. See Note 4 included in these consolidated financial statements for CECL related disclosures.
Loans Held for Sale
Loans Held for Sale

Although the Company generally holds its target investments as long-term investments, the Company occasionally classifies some of its investments as held for sale. Investments held for sale are carried at fair value within loans held for sale, at fair value in the Company’s consolidated balance sheets, with changes in fair value recorded through earnings.
Real Estate Owned
Real Estate Owned

Real estate assets are carried at their estimated fair value at acquisition and are presented net of accumulated depreciation or amortization and impairment charges. The Company allocates the purchase price of acquired real estate assets based on the fair value of the acquired land, buildings and improvements, furniture, fixtures and equipment, intangible assets and intangible liabilities, as applicable.
Real estate assets are depreciated or amortized using the straight-line method over estimated useful lives of up to 40 years for buildings and improvements, up to 15 years for furniture, fixtures and equipment and over the lease terms for intangible assets and liabilities. Renovations and/or replacements that improve or extend the life of the real estate asset are capitalized and depreciated over their estimated useful lives. The cost of ordinary repairs and maintenance are expensed as incurred. Other than amortization related to intangible assets and liabilities for above-market or below-market leases, depreciation or amortization expense related to real estate assets is included within expenses from real estate owned in the Company’s consolidated statements of operations. Amortization for above-market or below-market leases is recognized as an adjustment to rental revenue and is included within revenue from real estate owned in the Company’s consolidated statements of operations.

Real estate assets are evaluated for indicators of impairment on a quarterly basis. Factors that the Company may consider in its impairment analysis include, among others: (1) significant underperformance relative to historical or anticipated operating results; (2) significant negative industry or economic trends; (3) costs necessary to extend the life or improve the real estate asset; (4) significant increase in competition; and (5) ability to hold and dispose of the real estate asset in the ordinary course of business. A real estate asset is considered impaired when the sum of estimated future undiscounted cash flows expected to be generated by the real estate asset over the estimated remaining holding period is less than the carrying amount of such real estate asset. Cash flows include operating cash flows and anticipated capital proceeds generated by the real estate asset. An impairment charge is recorded equal to the excess of the carrying value of the real estate asset over the fair value. When determining the fair value of a real estate asset, the Company makes certain assumptions including, but not limited to, consideration of projected operating cash flows, comparable selling prices and projected cash flows from the eventual disposition of the real estate asset based upon the Company’s estimate of a capitalization rate and discount rate.

The Company reviews its real estate assets, from time to time, in order to determine whether to sell such assets. Real estate assets are classified as held for sale when the Company commits to a plan to sell the asset, when the asset is being actively marketed for sale at a reasonable price and the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year. Real estate assets that are held for sale are carried at the lower of the asset’s carrying amount or its fair value less costs to sell.
Available-for-Sale Debt Securities
Available-for-Sale Debt Securities

The Company acquires debt securities that are collateralized by mortgages on CRE properties primarily for short-term cash management and investment purposes. On the acquisition date, the Company designates investments in CRE debt securities as available-for-sale. Investments in CRE debt securities that are classified as available-for-sale are carried at fair value. Unrealized holding gains and losses for available-for-sale debt securities are recorded each period in other comprehensive income (“OCI”). The Company uses a specific identification method when determining the cost of a debt security sold and the amount of unrealized gain or loss reclassified from accumulated other comprehensive income (loss) into earnings.

Available-for-sale debt securities that are in an unrealized loss position are evaluated on a quarterly basis to determine whether declines in the fair value below the amortized cost basis qualify as other than temporary impairment (“OTTI”). The OTTI assessment is performed at the individual security level. In assessing whether the entire amortized cost basis of each security will be recovered, the Company will compare the present value of cash flows expected to be collected from the security with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the entire amortized cost basis of the security will not be recovered and an OTTI shall be considered to have occurred.
Available-for-sale debt securities are generally placed on non-accrual status when principal or interest payments are past due 30 days or more or when there is reasonable doubt that principal or interest will be collected in full. Accrued and unpaid interest is generally reversed against interest income in the period the debt security is placed on non-accrual status. Interest payments received on non-accrual securities may be recognized as income or applied to reduce amortized cost basis depending upon management’s judgment regarding collectability of the debt security. Non-accrual debt securities are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current.
Debt Issuance Costs
Debt Issuance Costs

Debt issuance costs under the Company’s indebtedness are capitalized and amortized over the term of the respective debt instrument. Unamortized debt issuance costs are expensed when the associated debt is repaid prior to maturity. Debt issuance costs related to debt securitizations are capitalized and amortized over the term of the underlying loans using the effective interest method. When an underlying loan is prepaid in a debt securitization and the outstanding principal balance of
the securitization debt is reduced, the related unamortized debt issuance costs are charged to expense based on a pro‑rata share of the debt issuance costs being allocated to the specific loans that were prepaid. Amortization of debt issuance costs is included within interest expense, except as noted below, in the Company’s consolidated statements of operations while the unamortized balance on the (i) Secured Funding Agreements (each individually defined in Note 6 included in these consolidated financial statements) is included within other assets and (ii) Notes Payable, the Secured Term Loan (each defined in Note 6 included in these consolidated financial statements) and debt securitizations are each included as a reduction to the carrying amount of the liability, in the Company’s consolidated balance sheets.
Derivative Financial Instruments
Derivative Financial Instruments

Derivative financial instruments are classified as either other assets (gain positions) or other liabilities (loss positions) in the Company’s consolidated balance sheets at fair value. These amounts may be offset to the extent that there is a legal right to offset and if elected by management.

On the date the Company enters into a derivative contract, the Company designates each contract as a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability, or cash flow hedge, or as a derivative instrument not to be designated as a hedging derivative, or non-designated hedge. For all derivatives other than those designated as non-designated hedges, the Company formally documents the hedge relationships and designation at the contract’s inception. This documentation includes the identification of the hedging instruments and the hedged items, its risk management objectives, strategy for undertaking the hedge transaction and an evaluation of the effectiveness of its hedged transaction.

The Company performs a formal assessment on a quarterly basis on whether the derivative designated in each hedging relationship is expected to be, and has been, highly effective in offsetting changes in the value or cash flows of the hedged items. Changes in the fair value of derivative contracts are recorded each period in either current earnings or OCI, depending on whether the derivative is designated as part of a hedge transaction and, if so, the type of hedge transaction. For derivatives that are designated as cash flow hedges, the effective portion of the unrealized gains or losses on these contracts is recorded in OCI. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued and the changes in fair value of the instrument are included in current earnings prospectively. The Company does not enter into derivatives for trading or speculative purposes.
Revenue Recognition
Revenue Recognition

Interest income is accrued based on the outstanding principal amount and the contractual terms of each loan or debt security. For loans held for investment, the origination fees, contractual exit fees and direct origination costs are also recognized in interest income over the initial loan term as a yield adjustment using the effective interest method. For available-for-sale debt securities, premiums or discounts are amortized or accreted into interest income as a yield adjustment using the effective interest method.

    Revenue from real estate owned represents revenue associated with the operations of a mixed-use property classified as real estate owned that was acquired in September 2023.

Revenue from the operation of the mixed-use property consists primarily of rental revenue from operating leases. For each operating lease with scheduled rent increases over the term of the lease, the Company recognizes rental revenue on a straight-line basis over the lease term when collectability of the lease payment is probable. Variable lease payments are recognized as rental revenue in the period when the changes in facts and circumstances on which the variable lease payments are based occur. Certain of the Company’s mixed-use property leases also contain provisions for tenants to reimburse the Company for property operating expenses. Such reimbursements are included in rental revenue on a gross basis. Rental revenue also includes amortization of intangible assets and liabilities related to above and below-market leases.
Net Interest Margin and Interest Expense
Net Interest Margin and Interest Expense
Net interest margin in the Company’s consolidated statements of operations serves to measure the performance of the Company’s loans and debt securities as compared to its use of debt leverage. The Company includes interest income from its loans and debt securities and interest expense related to its Secured Funding Agreements, Notes Payable, securitization debt and the Secured Term Loan (each individually defined in Note 6 included in these consolidated financial statements) in net interest margin.
Comprehensive Income
Comprehensive Income
Comprehensive income consists of net income (loss) and OCI that are excluded from net income (loss).
v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Interest Expense For the three months ended March 31, 2024 and 2023, interest expense is comprised of the following ($ in thousands):
For the Three Months Ended March 31,
 20242023
Secured funding agreements $12,877 $12,311 
Notes payable1,999 1,759 
Securitization debt12,187 11,606 
Secured term loan1,756 1,734 
Other (1)— (4,411)
Interest expense$28,819 $22,999 
______________________________
(1)    Represents the net interest expense recognized from the Company’s derivative financial instruments upon periodic settlement.
v3.24.1.u1
LOANS HELD FOR INVESTMENT (Tables)
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Schedule of Loans Held for Investments
The Company’s investments in loans held for investment are accounted for at amortized cost. The following tables summarize the Company’s loans held for investment as of March 31, 2024 and December 31, 2023 ($ in thousands):

 As of March 31, 2024
Carrying Amount (1)Outstanding Principal (1)Weighted Average Unleveraged Effective YieldWeighted Average Remaining Life (Years)
Senior mortgage loans $1,970,558 $1,996,099 8.0 %(2)9.2 %(3)1.0
Subordinated debt and preferred equity investments43,942 48,849 6.4 %(2)15.3 %(3)1.9
Total loans held for investment portfolio $2,014,500 $2,044,948 7.9 %(2)9.3 %(3)1.0
 As of December 31, 2023
Carrying Amount (1)
Outstanding Principal (1)
Weighted Average Unleveraged Effective YieldWeighted Average Remaining Life (Years)
Senior mortgage loans $2,090,146 $2,118,947 7.5 %(2)9.3 %(3)1.1
Subordinated debt and preferred equity investments36,378 39,098 8.1 %(2)15.3 %(3)1.8
Total loans held for investment portfolio$2,126,524 $2,158,045 7.5 %(2)9.4 %(3)1.1
______________________________

(1)The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds.
(2)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of March 31, 2024 and December 31, 2023 as weighted by the total outstanding principal balance of each loan.
(3)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all interest accruing loans held by the Company as of March 31, 2024 and December 31, 2023 as weighted by the total outstanding principal balance of each interest accruing loan (excludes loans on non-accrual status as of March 31, 2024 and December 31, 2023).
Schedule of Current Investment Portfolio
A more detailed listing of the Company’s loans held for investment portfolio based on information available as of March 31, 2024 is as follows ($ in millions):

Loan Type
LocationOutstanding Principal (1)Carrying Amount (1)Interest RateUnleveraged Effective Yield (2)Maturity Date (3)Payment Terms (4)
Senior Mortgage Loans:
OfficeIL$160.2$154.0(5)7.6%(5)Mar 2025I/O
MultifamilyNY132.2131.5S+3.90%9.7%Jun 2025I/O
OfficeDiversified109.0108.8S+3.75%9.3%Jan 2025P/I(6)
IndustrialIL100.7100.7S+4.65%10.4%May 2024I/O
MultifamilyTX97.597.1S+3.00%(7)8.8%Jul 2025I/O
Residential/CondoNY96.288.3S+8.95%—%(8)Dec 2025(8)I/O
Mixed-useNY76.376.3S+3.75%9.4%Jul 2024I/O
Residential/CondoFL75.075.0S+5.35%10.7%Jul 2024I/O
OfficeAZ71.871.6S+3.61%9.4%Oct 2024I/O
OfficeNC68.968.8S+3.65%9.4%Aug 2024I/O
OfficeNC68.665.5S+4.35%—%(9)May 2024(9)P/I(6)
MultifamilyTX68.468.3S+2.95%8.7%Dec 2024I/O
Multifamily/OfficeSC67.066.9S+3.00%8.6%Nov 2024I/O
OfficeNY59.059.0S+2.65%8.0%(10)Jul 2027(10)I/O
MultifamilyOH57.056.5S+3.05%8.8%Oct 2026I/O
OfficeIL56.055.8S+4.25%10.1%Jan 2025I/O
HotelNY52.952.6S+4.40%10.1%Mar 2026I/O
HotelCA50.950.7S+4.20%10.0%Mar 2025I/O
OfficeMA50.149.7S+3.75%9.9%Apr 2025I/O
OfficeGA48.448.3S+3.15%8.7%Dec 2024P/I(6)
IndustrialMA47.547.2S+2.90%8.4%Jun 2028I/O
Mixed-useTX35.335.3S+3.85%9.4%Sep 2024I/O
OfficeCA33.230.6S+3.45%—%(11)Dec 2023(11)I/O
MultifamilyCA31.731.6S+3.00%8.6%Dec 2025I/O
MultifamilyPA28.228.2S+2.50%7.8%Dec 2025I/O
IndustrialNJ27.827.8S+3.85%9.8%May 2024I/O
IndustrialFL25.525.4S+3.00%8.6%Dec 2025I/O
MultifamilyWA23.123.0S+3.00%8.5%Nov 2025I/O
MultifamilyTX23.023.0S+2.60%8.3%Oct 2024I/O
OfficeCA20.420.3S+3.50%9.1%Nov 2025P/I(6)
IndustrialCA19.618.7S+3.85%—%(12)Sep 2024I/O
Student HousingAL19.519.4S+3.95%9.6%May 2024I/O
Self StoragePA18.218.1S+3.00%8.6%Dec 2025I/O
Self StorageNJ17.617.5S+2.90%9.0%Apr 2025I/O
Self StorageWA11.511.4S+2.90%9.0%Mar 2025I/O
Self StorageIN11.011.0S+3.60%9.0%Jun 2026I/O
IndustrialTX10.010.0S+5.35%11.1%Dec 2024I/O
Self StorageMA7.77.7S+3.00%8.5%Nov 2024I/O
Self StorageMA6.86.7S+3.00%8.5%Oct 2024I/O
IndustrialTN6.46.4S+5.60%11.3%Nov 2024I/O
Self StorageNJ5.95.9S+3.00%8.8%Jul 2024I/O
Subordinated Debt and Preferred
Equity Investments:
MultifamilySC20.620.5S+9.53%15.3%Sep 2025I/O
OfficeNJ18.515.812.00%—%(13)Jan 2026I/O
OfficeNY9.87.65.50%—%(10)Jul 2027(10)I/O
Total/Weighted Average $2,044.9$2,014.57.9%
_________________________

(1)The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discounts, deferred loan fees and origination costs and cost-recovery proceeds. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 13 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.
(2)Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts)
and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on SOFR as of March 31, 2024 or the SOFR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of March 31, 2024 as weighted by the outstanding principal balance of each loan.
(3)Reflects the initial loan maturity date excluding any contractual extension options. Certain loans are subject to contractual extension options that generally vary between one and two 12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
(4)I/O = interest only, P/I = principal and interest.
(5)The Illinois loan is structured as both a senior and mezzanine loan with the Company holding both positions. The senior position has a per annum interest rate of S + 2.25% and the mezzanine position has a fixed per annum interest rate of 10.00%. The mezzanine position of this loan, which had an outstanding principal balance of $46.2 million as of March 31, 2024, was on non-accrual status as of March 31, 2024 and therefore, the Unleveraged Effective Yield presented is for the senior position only as the mezzanine position is non-interest accruing. As of March 31, 2024, the borrower is current on all contractual interest payments.
(6)In April 2022, amortization began on the senior North Carolina loan, which had an outstanding principal balance of $68.6 million as of March 31, 2024. In January 2023, amortization began on the senior Georgia loan, which had an outstanding principal balance of $48.4 million as of March 31, 2024. In February 2023, amortization began on the senior diversified loan, which had an outstanding principal balance of $109.0 million as of March 31, 2024. In December 2023, amortization began on the senior California loan, which had an outstanding principal balance of $20.4 million as of March 31, 2024. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
(7)In March 2024, the Company and the borrower entered into a modification agreement to, among other things, reduce the interest rate on the senior Texas loan from S+3.50% to S+3.00%.
(8)The New York loan is structured as both a senior and mezzanine loan with the Company holding both positions. The senior and mezzanine positions each have a per annum interest rate of S + 8.95%. The senior and mezzanine loans were both on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the New York loan from April 2024 to December 2025.
(9)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, extend the maturity date on the senior North Carolina loan from March 2024 to May 2024. For the three months ended March 31, 2024, the Company received $1.7 million of interest payments in cash on the senior North Carolina loan that was recognized as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments. See Note 16 included in these consolidated financial statements for a subsequent event related to the senior North Carolina loan.
(10)In March 2024, the Company and the borrower entered into a modification and extension agreement to, among other things, split the existing senior New York loan, which was on non-accrual status and had an outstanding principal balance of $73.8 million at the time of the modification, into a senior A-Note with an outstanding principal balance of $60.0 million and a subordinated B-Note with an outstanding principal balance of $13.8 million. In conjunction with the modification, the borrower repaid the outstanding principal of the senior A-Note down to $59.0 million and the subordinated B-Note down to $9.8 million. The subordinated B-Note is subordinate to new sponsor equity related to the loan paydown and additional capital contributions. In addition, the maturity date of the senior A-Note and the subordinated B-Note was extended from August 2025 to July 2027. The senior A-Note has a per annum interest rate of S + 2.65% and the subordinated B-Note has a fixed per annum interest rate of 5.50%. During the three months ended March 31, 2024, the senior A-Note, which had an outstanding principal balance of $59.0 million as of March 31, 2024, was restored to accrual status. As of March 31, 2024, the subordinated B-Note, which had an outstanding principal balance of $9.8 million, was on non-accrual status and therefore, the Unleveraged Effective Yield is not applicable. As of March 31, 2024, the borrower is current on all contractual interest payments for the senior A-Note and the subordinated B-Note.
(11)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. As of March 31, 2024, the senior California loan, which is collateralized by an office property, is in maturity default due to the failure of the borrower to repay the outstanding principal balance of the loan by the December 2023 maturity date. The Company is in the process of a foreclosure of the property. Once legal title of the property is acquired, the Company will derecognize the senior California loan and recognize the office property as real estate owned.
(12)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. For the three months ended March 31, 2024, the Company received $454 thousand of interest payments in cash on the senior California loan that was recognized as a reduction to the carrying value of the loan and the borrower is current on all contractual interest payments.
(13)Loan was on non-accrual status as of March 31, 2024 and the Unleveraged Effective Yield is not applicable. The mezzanine New Jersey loan is currently in default due to the borrower not making its contractual interest payments due subsequent to the December 2023 interest payment date. For the three months ended March 31, 2024, the Company received $37 thousand of interest payments in cash on the mezzanine New Jersey loan that was recognized as a reduction to the carrying value of the loan.
Schedule of Activity in Loan Portfolio
For the three months ended March 31, 2024, the activity in the Company’s loan portfolio was as follows ($ in thousands):
Balance at December 31, 2023$2,126,524 
Initial funding— 
Origination and other loan fees and discounts, net of costs(232)
Additional funding 13,035 
Amortizing payments(3,389)
Loan payoffs (1)(122,685)
Origination and other loan fees and discount accretion 1,247 
Balance at March 31, 2024$2,014,500 
_________________________

(1)    Amount includes the carrying value of certain loans where the carrying value exceeded the net proceeds received from the payoff of the loan. In February 2024, the Company received a discounted payoff on a senior mortgage loan with outstanding principal of $18.8 million, which was collateralized by a multifamily property located in Washington, in conjunction with a short sale of the multifamily property by the borrower to a third party. At the time of the discounted payoff, the senior mortgage loan was in default due to the failure of the borrower to repay the outstanding principal balance of the loan by the September 2023 maturity date. For the three months ended March 31, 2024, the Company recognized a realized loss of $1.7 million in the Company’s consolidated statements of operations as the carrying value of the senior mortgage loan exceeded the net proceeds from the payoff of the loan. In addition, in March 2024, the Company received a discounted payoff on a senior mortgage loan with outstanding principal of $56.9 million, which was collateralized by an office property located in Illinois, in conjunction with a short sale of the office property by the borrower to a third party. At the time of the discounted payoff, the senior mortgage loan was in default due to the failure of the borrower to repay the outstanding principal balance of the loan by the February 2024 maturity date. For the three months ended March 31, 2024, the Company recognized a realized loss of $43.1 million in the Company’s consolidated statements of operations as the carrying value of the senior mortgage loan exceeded the net proceeds from the payoff of the loan.
v3.24.1.u1
CURRENT EXPECTED CREDIT LOSSES (Tables)
3 Months Ended
Mar. 31, 2024
Credit Loss [Abstract]  
Schedule of Financing Receivable, Allowance for Credit Loss
Activity related to the CECL Reserve for outstanding balances on the Company’s loans held for investment as of and for the three months ended March 31, 2024 was as follows ($ in thousands):
Balance at December 31, 2023 (1)
$159,885 
Provision for current expected credit losses(20,122)
Write-offs— 
Recoveries— 
Balance at March 31, 2024 (1)
$139,763 
__________________________

(1)     The CECL Reserve related to outstanding balances on loans held for investment is recorded within current expected credit loss reserve in the Company’s consolidated balance sheets.

Current Expected Credit Loss Reserve for Unfunded Loan Commitments    

Activity related to the CECL Reserve for unfunded commitments on the Company’s loans held for investment as of and for the three months ended March 31, 2024 was as follows ($ in thousands):

Balance at December 31, 2023 (1)
$3,248 
Provision for current expected credit losses(2,147)
Write-offs— 
Recoveries — 
Balance at March 31, 2024 (1)
$1,101 
__________________________

(1)     The CECL Reserve related to unfunded commitments on loans held for investment is recorded within other liabilities in the Company’s consolidated balance sheets.
Schedule of Company Loan Risk Definitions Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows:
Ratings    Definition
1Very Low Risk
2Low Risk
3Medium Risk
4High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance
5Impaired/Loss Likely: A loan that has a significantly increased probability of default and principal loss
Schedule of Financing Receivable Credit Quality Indicators
As of March 31, 2024, the carrying value, excluding the CECL Reserve, of the Company’s loans held for investment within each risk rating by year of origination is as follows ($ in thousands):
20242023202220212020PriorTotal
Risk rating:
1$$$37,800$$$$37,800
2103,75111,446163,85120,320299,368
311,003378,815589,351108,815111,8041,199,788
4185,3487,586153,96484,160431,058
546,48646,486
Total$$114,754$613,409$760,788$262,779$262,770$2,014,500
v3.24.1.u1
REAL ESTATE OWNED (Tables)
3 Months Ended
Mar. 31, 2024
Real Estate Owned [Abstract]  
Schedule of Real Estate Properties
The following table summarizes the Company’s real estate owned as of March 31, 2024 and December 31, 2023 ($ in thousands):

As of
March 31, 2024December 31, 2023
Land$21,337 $21,337 
Buildings and improvements52,224 52,224 
In-place lease intangibles21,276 21,276 
Above-market lease intangibles547 547 
Below-market lease intangibles(11,084)(11,084)
Total real estate owned84,300 84,300 
Less: Accumulated depreciation and amortization (1,801)(1,016)
Real estate owned, net$82,499 $83,284 
Schedule of Intangible Lease Assets and Liabilities
The following table summarizes the Company’s intangible lease assets and liabilities that are included within real estate owned as of March 31, 2024 and December 31, 2023 ($ in thousands):

As of March 31, 2024As of December 31, 2023
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Assets:
In-place lease intangibles$21,276 $(1,355)$19,921 $21,276 $(767)$20,509 
Above-market lease intangibles547 (62)485 547 (35)512 
Liabilities:
Below-market lease intangibles(11,084)579 (10,505)(11,084)322 (10,762)
Schedule of Amortization of Intangible Lease Assets and Liabilities
The following table summarizes the amortization of intangible lease assets and liabilities for the three months ended March 31, 2024 ($ in thousands):

Consolidated Statement
of Operations Location
Amount
Assets:
In-place lease intangiblesExpenses from real estate owned$588 
Above-market lease intangiblesRevenue from real estate owned(28)
Liabilities:
Below-market lease intangiblesRevenue from real estate owned257 
Schedule of Estimated Net Amortization Intangible Lease Assets and Liabilities
The following table summarizes the estimated net amortization schedule for the Company’s intangible lease assets and liabilities that are included within real estate owned as of March 31, 2024 ($ in thousands):

In-PlaceAbove-Market Below-Market
Lease IntangiblesLease IntangiblesLease Intangibles
Remainder of 2024$1,716 $84 $(771)
20252,23291(1,027)
20261,82176(618)
20271,70151(571)
20281,60341(542)
Thereafter10,848142(6,976)
Total$19,921 $485 $(10,505)
Schedule of the Future Minimum Contractual Lease to be Received, Maturity
The following table summarizes the future minimum contractual lease payments to be collected by the Company under non-cancelable operating leases, excluding tenant reimbursements of expenses and variable lease payments, as of March 31, 2024 ($ in thousands):

Remainder of 2024$7,521 
202510,106
202610,224
20279,989
20289,976
Thereafter34,332
Total$82,148 
v3.24.1.u1
DEBT (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Outstanding Balances and Total Commitments Under Financing Agreements As of March 31, 2024 and December 31, 2023, the outstanding balances and total commitments under the Financing Agreements consisted of the following ($ in thousands):
March 31, 2024December 31, 2023
Outstanding BalanceTotal
Commitment
Outstanding BalanceTotal
Commitment
Secured Funding Agreements:
Wells Fargo Facility$216,522 $450,000 (1)$208,540 $450,000 (1)
Citibank Facility204,104 325,000 221,604 325,000 
CNB Facility— 75,000 — 75,000 
MetLife Facility— 180,000 — 180,000 
Morgan Stanley Facility209,673 250,000 209,673 250,000 
Subtotal$630,299 $1,280,000 $639,817 $1,280,000 
Notes Payable $105,000 $105,000 $105,000 $105,000 
Secured Term Loan$150,000 $150,000 $150,000 $150,000 
   Total$885,299 $1,535,000 $894,817 $1,535,000 
______________________________

(1)The maximum commitment for the Wells Fargo Facility (as defined below) may be increased to up to $500.0 million at the Company’s option, subject to the satisfaction of certain conditions, including payment of an upsize fee.
v3.24.1.u1
COMMITMENTS AND CONTINGENCIES (Tables)
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Loan Commitments
As of March 31, 2024 and December 31, 2023, the Company had the following commitments to fund various senior mortgage loans, subordinated debt investments, as well as preferred equity investments accounted for as loans held for investment ($ in thousands):
As of
March 31, 2024December 31, 2023
Total commitments $2,141,364 $2,274,584 
Less: funded commitments (2,044,948)(2,158,045)
Total unfunded commitments $96,416 $116,539 
v3.24.1.u1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Restricted Stock Award Activity
The following tables summarize the (i) non-vested shares of restricted stock and RSUs and (ii) vesting schedule of shares of restricted stock and RSUs for the Company’s directors and officers and employees of the Manager as of March 31, 2024:

Schedule of Non-Vested Share and Share Equivalents
 Restricted Stock Grants—DirectorsRSUs—Officers and Employees of the ManagerTotal
Balance at December 31, 202334,215 1,063,366 1,097,581 
Granted — — — 
Vested (16,485)(273,388)(289,873)
Forfeited — (3,750)(3,750)
Balance at March 31, 202417,730 786,228 803,958 
Schedule of Future Anticipated Vesting Schedule of Restricted Stock Awards
Future Anticipated Vesting Schedule
Restricted Stock Grants—DirectorsRSUs—Officers and Employees of the ManagerTotal
Remainder of 202417,313 5,431 22,744 
2025417 359,885 360,302 
2026— 278,278 278,278 
2027— 142,634 142,634 
2028— — — 
Total 17,730 786,228 803,958 
v3.24.1.u1
EARNINGS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Computations of Basic and Diluted Earnings (loss) Per Share
The following information sets forth the computations of basic and diluted earnings per common share for the three months ended March 31, 2024 and 2023 ($ in thousands, except share and per share data):

For the Three Months Ended March 31,
20242023
Net income (loss) attributable to common stockholders$(12,323)$(6,439)
Divided by:
Basic weighted average shares of common stock outstanding:54,396,397 54,591,650 
Weighted average non-vested restricted stock and RSUs (1)— — 
Diluted weighted average shares of common stock outstanding:54,396,397 54,591,650 
Basic earnings (loss) per common share$(0.23)$(0.12)
Diluted earnings (loss) per common share$(0.23)$(0.12)
_______________________________
(1)    For the three months ended March 31, 2024 and 2023, the weighted average non-vested restricted stock and RSUs of 813,763 and 682,620 shares, respectively, were excluded from the computation of diluted earnings (loss) per common share as the impact of including those shares would be anti-dilutive.
v3.24.1.u1
INCOME TAX (Tables)
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of the TRS's Income Tax Provision
The income tax provision for the Company and the TRSs consisted of the following for the three months ended March 31, 2024 and 2023 ($ in thousands):
For the Three Months Ended March 31,
20242023
Current $— $10 
Deferred — 
Excise tax — 100 
   Total income tax expense, including excise tax$$110 
v3.24.1.u1
FAIR VALUE (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Debt Securities, Available-for-Sale The following tables summarize the Company’s investments in available-for-sale debt securities as of March 31, 2024 and December 31, 2023 ($ in thousands):
As of March 31, 2024
Face AmountAmortized CostUnamortized DiscountUnrealized Gain (Loss), Net
Available-for-sale debt securities$28,000 $27,913 $87 $235 


As of December 31, 2023
Face AmountAmortized CostUnamortized DiscountUnrealized Gain (Loss), Net
Available-for-sale debt securities$28,000 $27,906 $94 $154 
Schedule of Fair Value, Assets Measured on Recurring Basis
The following tables summarize the financial assets measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 ($ in thousands):
As of March 31, 2024
Level 1Level 2Level 3Total
Financial assets:
Available-for-sale debt securities$— $28,148 $— $28,148 
As of December 31, 2023
Level 1Level 2Level 3Total
Financial assets:
Loans held for sale$— $— $38,981 $38,981 
Available-for-sale debt securities— 28,060 — 28,060 
Schedule of Carrying Value and Estimated Fair Value of the Company's Financial Instruments Not Carried at Fair Value on the Consolidated Balance Sheet
As of March 31, 2024 and December 31, 2023, the carrying values and fair values of the Company’s financial assets and liabilities recorded at cost are as follows ($ in thousands):
As of
March 31, 2024December 31, 2023
Level in Fair Value HierarchyCarrying ValueFair
Value
Carrying ValueFair
Value
Financial assets:
   Loans held for investment3$2,014,500 $1,870,433 $2,126,524 $1,944,718 
Financial liabilities:
   Secured funding agreements2$630,299 $630,299 $639,817 $639,817 
   Notes payable 2104,714 105,000 104,662 105,000 
   Secured term loan3149,443 135,372 149,393 134,024 
Collateralized loan obligation securitization debt (consolidated VIEs)2595,105 586,195 723,117 705,033 
v3.24.1.u1
RELATED PARTY TRANSACTIONS (Tables)
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Schedule of Related-Party Costs Incurred by the Company and Amounts Payable to the Manager
The following table summarizes the related party costs incurred by the Company for the three months ended March 31, 2024 and 2023, and amounts payable to the Company’s Manager as of March 31, 2024 and December 31, 2023 ($ in thousands):
IncurredPayable
For the Three Months Ended March 31,As of
20242023March 31, 2024December 31, 2023
Affiliate Payments
Management fees $2,768 $3,010 $2,768 $2,946 
Incentive fees— — — — 
General and administrative expenses 1,132 732 1,458 1,154 
Direct costs (1)44 20 55 35 
   Total$3,944 $3,762 $4,281 $4,135 
_______________________________
(1)    For the three months ended March 31, 2024 and 2023, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.
v3.24.1.u1
DIVIDENDS AND DISTRIBUTIONS (Tables)
3 Months Ended
Mar. 31, 2024
DIVIDENDS AND DISTRIBUTIONS  
Schedule of the Company's Dividends Declared
The following table summarizes the Company’s dividends declared during the three months ended March 31, 2024 and 2023 ($ in thousands, except per share data):

Date DeclaredRecord DatePayment DatePer Share AmountTotal Amount
February 22, 2024March 28, 2024April 16, 2024$0.25 $13,802 
Total cash dividends declared for the three months ended March 31, 2024$0.25 $13,802 
February 15, 2023March 31, 2023April 18, 2023$0.35 (1)$19,345 
Total cash dividends declared for the three months ended March 31, 2023$0.35 $19,345 
_______________________________
(1)     Consists of a regular cash dividend of $0.33 and a supplemental cash dividend of $0.02.
v3.24.1.u1
ORGANIZATION (Details)
3 Months Ended
Mar. 31, 2024
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of reportable segments 1
v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
Mar. 31, 2024
Property, Plant and Equipment [Line Items]  
Debt securities, available-for-sale, interest payments are past due 30 days
Furniture, Fixtures and Equipment  
Property, Plant and Equipment [Line Items]  
Useful life (in years) 15 years
Maximum | Buildings and improvements  
Property, Plant and Equipment [Line Items]  
Useful life (in years) 40 years
v3.24.1.u1
SIGNIFICANT ACCOUNTING POLICIES - Schedule of Interest Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest expense $ 28,819 $ 22,999
Secured funding agreements    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest expense 12,877 12,311
Notes Payable    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest expense 1,999 1,759
Securitization debt    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest expense 12,187 11,606
Secured term loan    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest expense 1,756 1,734
Other    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Other $ 0 $ (4,411)
v3.24.1.u1
LOANS HELD FOR INVESTMENT - Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
loan
Dec. 31, 2023
USD ($)
loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Number of loans originated or co-originated | loan 44  
Number of loans repaid or sold, since inception | loan 170  
Total commitment $ 2,200.0  
Loans held for investment 2,000.0  
Amount funded 13.0  
Amount of repayments $ 78.4  
Percentage of loans held for investment having LIBOR floors 70.00%  
Weighted average floor (as a percent) 1.17%  
Impact of COVID-19    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Number of loans in non-accrual status | loan 7 9
Financing receivable, non-accrual $ 266.5 $ 399.3
v3.24.1.u1
LOANS HELD FOR INVESTMENT - Loans held for Investments (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Carrying Amount $ 2,014,500   $ 2,126,524
Outstanding Principal $ 2,044,948   2,158,045
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans 7.90% 7.50%  
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans 9.30% 9.40%  
Weighted Average Remaining Life (Years) 1 year 1 year 1 month 6 days  
Senior mortgage loans      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Carrying Amount $ 1,970,558   2,090,146
Outstanding Principal $ 1,996,099   2,118,947
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans 8.00% 7.50%  
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans 9.20% 9.30%  
Weighted Average Remaining Life (Years) 1 year 1 year 1 month 6 days  
Subordinated debt and preferred equity investments      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Carrying Amount $ 43,942   36,378
Outstanding Principal $ 48,849   $ 39,098
Weighted Average Unleveraged Effective Yield, Including Non-accrual Loans 6.40% 8.10%  
Weighted Average Unleveraged Effective Yield, Excluding Non-accrual Loans 15.30% 15.30%  
Weighted Average Remaining Life (Years) 1 year 10 months 24 days 1 year 9 months 18 days  
v3.24.1.u1
LOANS HELD FOR INVESTMENT - Investment Portfolio (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
option
Dec. 31, 2023
USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 2,044,948 $ 2,158,045
Carrying Amount $ 2,014,500 $ 2,126,524
Unleveraged Effective Yield 7.90%  
Minimum    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Number of extension options | option 1  
Maximum    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Number of extension options | option 2  
Extension period of maturity date 12 months  
SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest Rate 2.00%  
Senior Mortgage Loans | NY | SOFR Plus 2.65% Due Jul 2027 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 73,800  
Office | IL    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 46,200  
Weighted average unleveraged effective yield 10.00%  
Office | NY | Subordinated B Note    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Weighted average unleveraged effective yield 5.50%  
Office | NJ    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest income $ 37  
Office | Senior Mortgage Loans | IL | SOFR Plus 2.25%, Due Mar 2025    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal 160,200  
Carrying Amount $ 154,000  
Unleveraged Effective Yield 7.60%  
Office | Senior Mortgage Loans | IL | SOFR Plus 2.25%, Due Mar 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest Rate 2.25%  
Office | Senior Mortgage Loans | IL | SOFR Plus 4.25% Due Jan 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 56,000  
Carrying Amount $ 55,800  
Interest Rate 4.25%  
Unleveraged Effective Yield 10.10%  
Office | Senior Mortgage Loans | NY | SOFR Plus 2.65% Due Jul 2027 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 59,000  
Carrying Amount $ 59,000  
Interest Rate 2.65%  
Unleveraged Effective Yield 8.00%  
Office | Senior Mortgage Loans | NY | SOFR Plus 2.65% Due Jul 2027 | SOFR | Senior A Note    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 60,000  
Interest Rate 2.65%  
Repayments of debt $ 59,000  
Financing receivable, accrual 59,000  
Office | Senior Mortgage Loans | NY | SOFR Plus 2.65% Due Jul 2027 | SOFR | Subordinated B Note    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal 13,800  
Repayments of debt 9,800  
Financing receivable, non-accrual 9,800  
Office | Senior Mortgage Loans | Diversified | SOFR Plus 3.75% Due Jan 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal 109,000  
Carrying Amount $ 108,800  
Interest Rate 3.75%  
Unleveraged Effective Yield 9.30%  
Office | Senior Mortgage Loans | AZ | SOFR Plus 3.61%, Due Oct 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 71,800  
Carrying Amount $ 71,600  
Interest Rate 3.61%  
Unleveraged Effective Yield 9.40%  
Office | Senior Mortgage Loans | NC | SOFR Plus 3.65% Due Aug 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 68,900  
Carrying Amount $ 68,800  
Interest Rate 3.65%  
Unleveraged Effective Yield 9.40%  
Office | Senior Mortgage Loans | NC | SOFR Plus 4.35% Due May 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 68,600  
Carrying Amount $ 65,500  
Interest Rate 4.35%  
Unleveraged Effective Yield 0.00%  
Office | Senior Mortgage Loans | MA | SOFR Plus 3.75% Due Apr 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 50,100  
Carrying Amount $ 49,700  
Interest Rate 3.75%  
Unleveraged Effective Yield 9.90%  
Office | Senior Mortgage Loans | GA | SOFR Plus 3.15%, Due Dec 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 48,400  
Carrying Amount $ 48,300  
Interest Rate 3.15%  
Unleveraged Effective Yield 8.70%  
Office | Senior Mortgage Loans | CA | SOFR Plus 3.45%, Due Dec 2023 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 33,200  
Carrying Amount $ 30,600  
Interest Rate 3.45%  
Unleveraged Effective Yield 0.00%  
Office | Senior Mortgage Loans | CA | SOFR Plus 3.50%, Due Nov 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 20,400  
Carrying Amount $ 20,300  
Interest Rate 3.50%  
Unleveraged Effective Yield 9.10%  
Office | Subordinated debt and preferred equity investments | NY    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Weighted average unleveraged effective yield 5.50%  
Office | Subordinated debt and preferred equity investments | NY | SOFR Plus 5.50% Due Jun 2027 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 9,800  
Carrying Amount $ 7,600  
Unleveraged Effective Yield 0.00%  
Office | Subordinated debt and preferred equity investments | NJ | SOFR Plus 12.00% Due Jan 2026 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 18,500  
Carrying Amount $ 15,800  
Interest Rate 12.00%  
Unleveraged Effective Yield 0.00%  
Multifamily | Senior Mortgage Loans | NY | SOFR Plus 3.90% Due Jun 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 132,200  
Carrying Amount $ 131,500  
Interest Rate 3.90%  
Unleveraged Effective Yield 9.70%  
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 3.00% Due Jul 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 97,500  
Carrying Amount $ 97,100  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.80%  
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 3.00% Due Jul 2025 | SOFR | Minimum    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest Rate 3.00%  
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 2.95% Due Dec 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 68,400  
Carrying Amount $ 68,300  
Interest Rate 2.95%  
Unleveraged Effective Yield 8.70%  
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 2.60% Due Oct 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 23,000  
Carrying Amount $ 23,000  
Interest Rate 2.60%  
Unleveraged Effective Yield 8.30%  
Multifamily | Senior Mortgage Loans | TX | SOFR Plus 3.50% Due Jul 2025 | SOFR | Maximum    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest Rate 3.50%  
Multifamily | Senior Mortgage Loans | OH | SOFR Plus 3.05% Due Oct 2026 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 57,000  
Carrying Amount $ 56,500  
Interest Rate 3.05%  
Unleveraged Effective Yield 8.80%  
Multifamily | Senior Mortgage Loans | CA | SOFR Plus 3.00% Due Dec 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 31,700  
Carrying Amount $ 31,600  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.60%  
Multifamily | Senior Mortgage Loans | PA | SOFR Plus 2.50% Due Dec 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 28,200  
Carrying Amount $ 28,200  
Interest Rate 2.50%  
Unleveraged Effective Yield 7.80%  
Multifamily | Senior Mortgage Loans | WA | SOFR Plus 3.00% Due Nov 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 23,100  
Carrying Amount $ 23,000  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.50%  
Multifamily | Subordinated debt and preferred equity investments | SC | SOFR Plus 9.53% Due Sep 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 20,600  
Carrying Amount $ 20,500  
Interest Rate 9.53%  
Unleveraged Effective Yield 15.30%  
Industrial | NC    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest income $ 1,700  
Industrial | CA    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest income 454  
Industrial | Senior Mortgage Loans | IL | SOFR Plus 4.65%, Due May 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal 100,700  
Carrying Amount $ 100,700  
Interest Rate 4.65%  
Unleveraged Effective Yield 10.40%  
Industrial | Senior Mortgage Loans | TX | SOFR Plus 5.35% Due Dec 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 10,000  
Carrying Amount $ 10,000  
Interest Rate 5.35%  
Unleveraged Effective Yield 11.10%  
Industrial | Senior Mortgage Loans | FL | SOFR Plus 3.00% Due Dec 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 25,500  
Carrying Amount $ 25,400  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.60%  
Industrial | Senior Mortgage Loans | MA | SOFR Plus 2.90% Due Jun 2028 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 47,500  
Carrying Amount $ 47,200  
Interest Rate 2.90%  
Unleveraged Effective Yield 8.40%  
Industrial | Senior Mortgage Loans | CA | SOFR Plus 3.85% Due Sep 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 19,600  
Carrying Amount $ 18,700  
Interest Rate 3.85%  
Unleveraged Effective Yield 0.00%  
Industrial | Senior Mortgage Loans | NJ | SOFR Plus 3.85%, Due May 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 27,800  
Carrying Amount $ 27,800  
Interest Rate 3.85%  
Unleveraged Effective Yield 9.80%  
Industrial | Senior Mortgage Loans | TN | SOFR Plus 5.60% Due Nov 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 6,400  
Carrying Amount $ 6,400  
Interest Rate 5.60%  
Unleveraged Effective Yield 11.30%  
Residential/Condo | Senior Mortgage Loans | NY | SOFR Plus 8.95% Due Dec 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 96,200  
Carrying Amount $ 88,300  
Interest Rate 8.95%  
Unleveraged Effective Yield 0.00%  
Residential/Condo | Senior Mortgage Loans | NY | SOFR Plus 8.95%, Due April 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Interest Rate 8.95%  
Residential/Condo | Senior Mortgage Loans | FL | SOFR Plus 5.35%, Due Jul 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 75,000  
Carrying Amount $ 75,000  
Interest Rate 5.35%  
Unleveraged Effective Yield 10.70%  
Mixed-use | Senior Mortgage Loans | NY | SOFR Plus 3.75% Due Jul 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 76,300  
Carrying Amount $ 76,300  
Interest Rate 3.75%  
Unleveraged Effective Yield 9.40%  
Mixed-use | Senior Mortgage Loans | TX | SOFR Plus 3.85% Due Sep 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 35,300  
Carrying Amount $ 35,300  
Interest Rate 3.85%  
Unleveraged Effective Yield 9.40%  
Multifamily/Office | Senior Mortgage Loans | SC | SOFR Plus 3.00%, Due Nov 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 67,000  
Carrying Amount $ 66,900  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.60%  
Hotel | Senior Mortgage Loans | NY | LIBOR Plus 4 .40% Due Mar 2026 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 52,900  
Carrying Amount $ 52,600  
Interest Rate 4.40%  
Unleveraged Effective Yield 10.10%  
Hotel | Senior Mortgage Loans | CA | SOFR Plus 4.20% Due Mar 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 50,900  
Carrying Amount $ 50,700  
Interest Rate 4.20%  
Unleveraged Effective Yield 10.00%  
Student Housing | Senior Mortgage Loans | AL | SOFR Plus 3.95% Due May 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 19,500  
Carrying Amount $ 19,400  
Interest Rate 3.95%  
Unleveraged Effective Yield 9.60%  
Self Storage | Senior Mortgage Loans | MA | SOFR Plus 3.00%, Due Nov 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 7,700  
Carrying Amount $ 7,700  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.50%  
Self Storage | Senior Mortgage Loans | MA | SOFR Plus 3.00%, Due Oct 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 6,800  
Carrying Amount $ 6,700  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.50%  
Self Storage | Senior Mortgage Loans | PA | SOFR Plus 3.00% Due Dec 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 18,200  
Carrying Amount $ 18,100  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.60%  
Self Storage | Senior Mortgage Loans | NJ | SOFR Plus 2.90% Due April 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 17,600  
Carrying Amount $ 17,500  
Interest Rate 2.90%  
Unleveraged Effective Yield 9.00%  
Self Storage | Senior Mortgage Loans | NJ | SOFR Plus 3.00% Due Jul 2024 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 5,900  
Carrying Amount $ 5,900  
Interest Rate 3.00%  
Unleveraged Effective Yield 8.80%  
Self Storage | Senior Mortgage Loans | WA | SOFR Plus 2.90% Due Mar 2025 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 11,500  
Carrying Amount $ 11,400  
Interest Rate 2.90%  
Unleveraged Effective Yield 9.00%  
Self Storage | Senior Mortgage Loans | IN | SOFR Plus 3.60%, Due Jun 2026 | SOFR    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Outstanding Principal $ 11,000  
Carrying Amount $ 11,000  
Interest Rate 3.60%  
Unleveraged Effective Yield 9.00%  
v3.24.1.u1
LOANS HELD FOR INVESTMENT - Portfolio Activity (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Feb. 29, 2024
Mar. 31, 2024
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Balance at the beginning of the period   $ 2,126,524
Initial funding   0
Origination and other loan fees and discounts, net of costs   (232)
Additional funding   13,035
Amortizing payments   (3,389)
Loan payoffs   (122,685)
Origination and other loan fees and discount accretion   1,247
Balance at the end of the period   2,014,500
Multifamily | WA    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Loan payoffs $ 18,800  
Multifamily | WA | Senior Mortgage Loans    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Mortgage loans on real estate loan, realized loss   (1,700)
Office | IL    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Loan payoffs   56,900
Office | IL | Senior Mortgage Loans    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Mortgage loans on real estate loan, realized loss   $ (43,100)
v3.24.1.u1
CURRENT EXPECTED CREDIT LOSSES - Narrative (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing receivable, allowance for credit loss, excluding accrued interest $ 140,900  
Allowance for credit loss, basis points 6.58%  
Commitments $ 2,141,364 $ 2,274,584
Outstanding Principal 2,044,948 2,158,045
Other Assets    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Interest receivable 12,600 13,000
Office | Senior Mortgage Loans | CA | 5 - Impaired/Loss Likely: A loan that has significantly increased probability of default or principal loss    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing receivable, allowance for credit loss, excluding accrued interest 14,700  
Office | Senior Mortgage Loans | CA | SOFR Plus 3.45%, Due Dec 2023 | SOFR    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Outstanding Principal 33,200  
Office | Senior Mortgage Loans | NJ | 5 - Impaired/Loss Likely: A loan that has significantly increased probability of default or principal loss    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing receivable, allowance for credit loss, excluding accrued interest 15,900  
Office | Subordinated debt and preferred equity investments | NJ | SOFR Plus 12.00% Due Jan 2026 | SOFR    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Outstanding Principal 18,500  
Loans Held for Investment    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing receivable, allowance for credit loss, excluding accrued interest 139,763 159,885
Unfunded Loan Commitment    
Financing Receivable, Allowance for Credit Loss [Line Items]    
Financing receivable, allowance for credit loss, excluding accrued interest $ 1,101 $ 3,248
v3.24.1.u1
CURRENT EXPECTED CREDIT LOSSES - Allowance for Credit Loss (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]    
Provision for current expected credit losses $ (22,269) $ 21,019
Balance at the end of the period 140,900  
Loans Held for Investment    
Financing Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at the beginning of the period 159,885  
Provision for current expected credit losses (20,122)  
Write-offs 0  
Recoveries 0  
Balance at the end of the period 139,763  
Unfunded Loan Commitment    
Financing Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at the beginning of the period 3,248  
Provision for current expected credit losses (2,147)  
Write-offs 0  
Recoveries 0  
Balance at the end of the period $ 1,101  
v3.24.1.u1
CURRENT EXPECTED CREDIT LOSSES - Internal Credit Risk Rating (Details) - Loans Held for Investment
$ in Thousands
Mar. 31, 2024
USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 $ 0
2023 114,754
2022 613,409
2021 760,788
2020 262,779
Prior 262,770
Total 2,014,500
1 - Very Low Risk  
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 0
2023 0
2022 37,800
2021 0
2020 0
Prior 0
Total 37,800
2 - Low Risk  
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 0
2023 103,751
2022 11,446
2021 163,851
2020 0
Prior 20,320
Total 299,368
3 - Medium Risk  
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 0
2023 11,003
2022 378,815
2021 589,351
2020 108,815
Prior 111,804
Total 1,199,788
4 - High Risk/Potential for Loss: Asset performance is trailing underwritten expectations. Loan at risk of impairment without material improvement to performance  
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 0
2023 0
2022 185,348
2021 7,586
2020 153,964
Prior 84,160
Total 431,058
5 - Impaired/Loss Likely: A loan that has significantly increased probability of default or principal loss  
Financing Receivable, Credit Quality Indicator [Line Items]  
2024 0
2023 0
2022 0
2021 0
2020 0
Prior 46,486
Total $ 46,486
v3.24.1.u1
REAL ESTATE OWNED - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Sep. 08, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding Principal $ 2,044,948   $ 2,158,045  
Real estate owned, net 82,499   83,284  
Depreciation and amortization of real estate owned 786 $ 0    
Mixed-Use Property | FL        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Real estate owned, net 82,499   83,284  
Total real estate owned 84,300   $ 84,300  
Impairment charges $ 0      
Weighted-average amortization periods     9 years 3 months 18 days  
Mixed-Use Property | Senior Mortgage Loans | FL        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Outstanding Principal       $ 82,900
Debt derecognized       82,900
Real estate owned, net       84,300
Other repossessed hotel assets       1,400
Total real estate owned       $ 82,900
v3.24.1.u1
REAL ESTATE OWNED - Schedule of Real Estate Owned, Net (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Real estate owned, net $ 82,499 $ 83,284
Mixed-Use Property | FL    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned 84,300 84,300
Less: Accumulated depreciation and amortization (1,801) (1,016)
Real estate owned, net 82,499 83,284
Mixed-Use Property | FL | Land    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned 21,337 21,337
Mixed-Use Property | FL | Buildings and improvements    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned 52,224 52,224
Mixed-Use Property | FL | Lease intangibles | In-place lease intangibles    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned 21,276 21,276
Mixed-Use Property | FL | Lease intangibles | Above-market lease intangibles    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned 547 547
Mixed-Use Property | FL | Lease intangibles | Below-market lease intangibles    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Total real estate owned $ 11,084 $ 11,084
v3.24.1.u1
REAL ESTATE OWNED - Schedule of Intangible Lease Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Below-market lease intangibles, gross $ (11,084) $ (11,084)
Below-market lease intangibles, accumulated amortization 579 322
Total (10,505) (10,762)
In-place lease intangibles    
Finite-Lived Intangible Assets [Line Items]    
Gross 21,276 21,276
Accumulated Amortization (1,355) (767)
Total 19,921 20,509
Above-market lease intangibles    
Finite-Lived Intangible Assets [Line Items]    
Gross 547 547
Accumulated Amortization (62) (35)
Total $ 485 $ 512
v3.24.1.u1
REAL ESTATE OWNED - Schedule of Amortization of Intangible Lease Assets and Liabilities (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
In-place lease intangibles | Expenses from real estate owned  
Finite-Lived Intangible Assets [Line Items]  
Expenses from real estate owned $ 588
Above-market lease intangibles | Revenue from real estate owned  
Finite-Lived Intangible Assets [Line Items]  
Amortization of above- and below- market lease intangibles (28)
Below-market lease intangibles | Revenue from real estate owned  
Finite-Lived Intangible Assets [Line Items]  
Amortization of Below Market Lease $ 257
v3.24.1.u1
REAL ESTATE OWNED - Schedule of Estimated Net Amortization Intangible Lease Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Below Market Lease, Net, Amortization Income, Fiscal Year Maturity [Abstract]    
Remainder of 2024 $ (771)  
2025 (1,027)  
2026 (618)  
2027 (571)  
2028 (542)  
Thereafter (6,976)  
Total (10,505) $ (10,762)
In-place lease intangibles    
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
Remainder of 2024 1,716  
2025 2,232  
2026 1,821  
2027 1,701  
2028 1,603  
Thereafter 10,848  
Total 19,921 20,509
Above-market lease intangibles    
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
Remainder of 2024 84  
2025 91  
2026 76  
2027 51  
2028 41  
Thereafter 142  
Total $ 485 $ 512
v3.24.1.u1
REAL ESTATE OWNED - Schedule of the Future Minimum Contractual Lease to be Received, Maturity (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]  
Remainder of 2024 $ 7,521
2025 10,106
2026 10,224
2027 9,989
2028 9,976
Thereafter 34,332
Total $ 82,148
v3.24.1.u1
DEBT - Schedule of Outstanding Balances and Total Commitments Under Financing Agreements (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Outstanding Balance $ 885,299,000 $ 894,817,000
Total Commitment 1,535,000,000 1,535,000,000
Secured term loan    
Debt Instrument [Line Items]    
Outstanding Balance 150,000,000 150,000,000
Total Commitment 150,000,000 150,000,000
Wells Fargo Facility | Revolving Credit Facility, Optional Commitment Amount    
Debt Instrument [Line Items]    
Total Commitment 500,000,000  
Secured Funding Facility    
Debt Instrument [Line Items]    
Outstanding Balance 630,299,000 639,817,000
Total Commitment 1,280,000,000 1,280,000,000
Secured Funding Facility | Wells Fargo Facility    
Debt Instrument [Line Items]    
Outstanding Balance 216,522,000 208,540,000
Total Commitment 450,000,000 450,000,000
Secured Funding Facility | Citibank Facility    
Debt Instrument [Line Items]    
Outstanding Balance 204,104,000 221,604,000
Total Commitment 325,000,000 325,000,000
Secured Funding Facility | CNB Facility    
Debt Instrument [Line Items]    
Outstanding Balance 0 0
Total Commitment 75,000,000 75,000,000
Secured Funding Facility | MetLife Facility    
Debt Instrument [Line Items]    
Outstanding Balance 0 0
Total Commitment 180,000,000 180,000,000
Secured Funding Facility | Morgan Stanley Facility    
Debt Instrument [Line Items]    
Outstanding Balance 209,673,000 209,673,000
Total Commitment 250,000,000 250,000,000
Notes Payable    
Debt Instrument [Line Items]    
Outstanding Balance 105,000,000 105,000,000
Total Commitment $ 105,000,000 $ 105,000,000
v3.24.1.u1
DEBT - Disclosures (Details)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 18 Months Ended
Jan. 31, 2024
Mar. 31, 2024
USD ($)
loan
option
extension
Mar. 31, 2023
USD ($)
Nov. 12, 2025
Nov. 12, 2026
Nov. 12, 2026
Dec. 31, 2023
USD ($)
Funding agreements              
Total Commitment   $ 1,535,000,000         $ 1,535,000,000
Outstanding Balance   885,299,000         894,817,000
Outstanding Principal   $ 2,044,948,000         2,158,045,000
SOFR              
Funding agreements              
Interest Rate   2.00%          
Minimum              
Funding agreements              
Number of extension options | option   1          
Maximum              
Funding agreements              
Extension period of maturity date   12 months          
Number of extension options | option   2          
ACRC Lender CO LLC              
Funding agreements              
Outstanding Balance   $ 105,000,000          
ACRC Lender CO LLC | Multifamily | Senior Mortgage Loans | NY              
Funding agreements              
Outstanding Balance   105,000,000          
Outstanding Principal   133,000,000          
Secured Revolving Funding Facility | Wells Fargo Facility              
Funding agreements              
Total Commitment   $ 450,000,000          
Number of extension periods available for maturity date | extension   2          
Extension period of maturity date   12 months          
Secured Revolving Funding Facility | Wells Fargo Facility | Minimum | One-month SOFR              
Funding agreements              
Interest rate margin (as a percent)   1.50%          
Secured Revolving Funding Facility | Wells Fargo Facility | Maximum | One-month SOFR              
Funding agreements              
Interest rate margin (as a percent)   3.75%          
Secured Revolving Funding Facility | Citibank Facility              
Funding agreements              
Total Commitment   $ 325,000,000          
Number of extension periods available for maturity date | extension   2          
Extension period of maturity date   12 months          
Non-utilization fee on average available balance (basis points)   0.25%          
Non-utilization fee   $ 0 $ 0        
Secured Revolving Funding Facility | Citibank Facility | Minimum | 30 day SOFR              
Funding agreements              
Interest rate margin (as a percent)   1.50%          
Secured Revolving Funding Facility | Citibank Facility | Maximum | 30 day SOFR              
Funding agreements              
Interest rate margin (as a percent)   2.10%          
Revolving Credit Facility, Optional Commitment Amount | Wells Fargo Facility              
Funding agreements              
Total Commitment   $ 500,000,000          
CNB Facility | CNB Facility              
Funding agreements              
Total Commitment   75,000,000          
Non-utilization fee   $ 71,000 70,000        
CNB Facility | CNB Facility | Federal Funds Rate              
Funding agreements              
Interest rate margin (as a percent)   2.25%          
Non-utilization fee on average available balance (basis points)   0.375%          
Facility used on average (at least) (as a percent)   75.00%          
CNB Facility | CNB Facility | Maximum | SOFR              
Funding agreements              
Interest rate margin (as a percent)   3.25%          
Revolving Credit Facility - Optional Funding Period | CNB Facility              
Funding agreements              
Extension period of maturity date 12 months            
Revolving Master Repurchase Facility | MetLife Facility              
Funding agreements              
Total Commitment   $ 180,000,000          
Non-utilization fee on average available balance (basis points)   0.25%          
Non-utilization fee   $ 74,000 $ 73,000        
Non-utilization threshold percentage (less than) (as a percent)   65.00%          
Revolving Master Repurchase Facility | MetLife Facility | 30 day SOFR              
Funding agreements              
Interest rate margin (as a percent)   2.50%          
Revolving Master Repurchase Facility | Morgan Stanley Facility              
Funding agreements              
Total Commitment   $ 250,000,000          
Number of extension periods available for maturity date | extension   1          
Extension period of maturity date   12 months          
Revolving Master Repurchase Facility | Morgan Stanley Facility | 30 day SOFR              
Funding agreements              
Interest rate margin (as a percent)   2.25%          
Revolving Master Repurchase Facility | Morgan Stanley Facility | Minimum | 30 day SOFR              
Funding agreements              
Interest rate margin (as a percent)   1.75%          
Notes Payable | ACRC Lender CO LLC              
Funding agreements              
Extension period of maturity date   12 months          
Number of extension options | loan   2          
Secured term loan              
Funding agreements              
Total Commitment   $ 150,000,000         150,000,000
Interest rate margin (as a percent)   0.50%          
Outstanding Balance   $ 150,000,000         $ 150,000,000
Aggregate principal amount   $ 150,000,000          
Debt discount on initial draw down (as a percent)   4.60% 4.60%        
Secured term loan | Forecast              
Funding agreements              
Interest rate during period       4.50%      
Interest rate, increase (decrease)         0.125%    
Interest rate, quarterly increase           0.25%  
v3.24.1.u1
DERIVATIVE FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Mar. 31, 2022
Interest Rate Swap | Designated as Hedging Instrument        
Derivative [Line Items]        
Derivative, notional amount     $ 30,000  
Interest Rate Cap        
Derivative [Line Items]        
Derivative, notional amount       $ 170,000
Other comprehensive income   $ 2,000    
Gain on derivative $ 456      
Interest Rate Cap | Designated as Hedging Instrument        
Derivative [Line Items]        
Interest rate caps, fixed rate (percent)       0.50%
v3.24.1.u1
COMMITMENTS AND CONTINGENCIES - Commitments to Fund (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]    
Total commitments $ 2,141,364 $ 2,274,584
Less: funded commitments (2,044,948) (2,158,045)
Total unfunded commitments $ 96,416 $ 116,539
v3.24.1.u1
STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Jul. 25, 2023
Jun. 30, 2018
Class of Stock [Line Items]      
Share repurchase program, authorized amount   $ 50.0  
Restricted Stock | Amended and Restated 2012 Equity Incentive Plan      
Class of Stock [Line Items]      
Shares available for grant (in shares)     2,490,000
Restricted Stock and Restricted Stock Units | Amended and Restated 2012 Equity Incentive Plan | Minimum      
Class of Stock [Line Items]      
Award vesting period (in years) 1 year    
Restricted Stock and Restricted Stock Units | Amended and Restated 2012 Equity Incentive Plan | Maximum      
Class of Stock [Line Items]      
Award vesting period (in years) 3 years    
v3.24.1.u1
STOCKHOLDERS' EQUITY - Disclosures (Details)
3 Months Ended
Mar. 31, 2024
shares
Restricted stock activity  
Balance at the beginning of the period (in shares) 1,097,581,000
Granted (in shares) 0
Vested (in shares) (289,873,000)
Forfeited (in shares) (3,750,000)
Balance at the end of the period (in shares) 803,958,000
Future Anticipated Vesting Schedule  
Remainder of 2024 (in shares) 22,744
2025 (in shares) 360,302
2026 (in shares) 278,278
2027 (in shares) 142,634
2028 (in shares) 0
Total (in shares) 803,958
Restricted Stock | Restricted Stock Grants—Directors  
Restricted stock activity  
Balance at the beginning of the period (in shares) 34,215,000
Granted (in shares) 0
Vested (in shares) (16,485,000)
Forfeited (in shares) 0
Balance at the end of the period (in shares) 17,730,000
Future Anticipated Vesting Schedule  
Remainder of 2024 (in shares) 17,313
2025 (in shares) 417
2026 (in shares) 0
2027 (in shares) 0
2028 (in shares) 0
Total (in shares) 17,730
Restricted Stock Units (RSUs) | RSUs—Officers and Employees of the Manager  
Restricted stock activity  
Balance at the beginning of the period (in shares) 1,063,366,000
Granted (in shares) 0
Vested (in shares) (273,388,000)
Forfeited (in shares) (3,750,000)
Balance at the end of the period (in shares) 786,228,000
Future Anticipated Vesting Schedule  
Remainder of 2024 (in shares) 5,431
2025 (in shares) 359,885
2026 (in shares) 278,278
2027 (in shares) 142,634
2028 (in shares) 0
Total (in shares) 786,228
v3.24.1.u1
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net income (loss) attributable to common stockholders, basic $ (12,323) $ (6,439)
Net income (loss) attributable to common stockholders, diluted $ (12,323) $ (6,439)
Divided by:    
Basic weighted average shares of common stock outstanding (in shares) 54,396,397 54,591,650
Weighted average non-vested restricted stock and RSUs (in shares) 0 0
Diluted weighted average shares of common stock outstanding (in shares) 54,396,397 54,591,650
Basic earnings (loss) per common share (in dollars per share) $ (0.23) $ (0.12)
Diluted earnings (loss) per common share (in dollars per share) $ (0.23) $ (0.12)
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 813,763 682,620
v3.24.1.u1
INCOME TAX - Schedule of Components of Income Tax (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Components of the company's income tax provision    
Total income tax expense, including excise tax $ 2 $ 110
ACRE Capital Sale    
Components of the company's income tax provision    
Current 0 10
Deferred 2 0
Excise tax 0 100
Total income tax expense, including excise tax $ 2 $ 110
v3.24.1.u1
FAIR VALUE - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
loan
investment
Dec. 31, 2023
loan
investment
Dec. 31, 2022
USD ($)
loan
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Number of loans transferred 0 1  
Number of loans that the fair value is expected to be received from third parties   1  
Number of debt securities for an aggregate purchase price     3
Debt securities for an aggregate purchase price | $     $ 27.9
Debt securities, available-for-sale, term     10 years
Number of debt security investments | investment 3 3  
Measurement Input, Cap Rate | Minimum      
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Real estate owned, measurement input 0.064    
Measurement Input, Cap Rate | Maximum      
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Real estate owned, measurement input 0.083    
Measurement Input, Discount Rate | Minimum      
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Real estate owned, measurement input 0.080    
Measurement Input, Discount Rate | Maximum      
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Real estate owned, measurement input 0.095    
SOFR      
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]      
Debt securities floating rate, investment grade rated     2.47%
v3.24.1.u1
FAIR VALUE - Available-For-Sale Debt Securities (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Fair Value Disclosures [Abstract]    
Face Amount $ 28,000 $ 28,000
Amortized Cost 27,913 27,906
Unamortized Discount 87 94
Unrealized Gain (Loss), Net $ 235 $ 154
v3.24.1.u1
FAIR VALUE - Derivative Assets Recurring (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Loans held for sale    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets   $ 38,981
Loans held for sale | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets   0
Loans held for sale | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets   0
Loans held for sale | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets   38,981
Available-for-sale debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets $ 28,148 28,060
Available-for-sale debt securities | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets 0 0
Available-for-sale debt securities | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets 28,148 28,060
Available-for-sale debt securities | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets $ 0 $ 0
v3.24.1.u1
FAIR VALUE - Carrying Value and Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Financial assets:    
Loans held for investment $ 2,014,500 $ 2,126,524
Financial liabilities:    
Collateralized loan obligation securitization debt (consolidated VIEs) 595,105 723,117
Carrying Value    
Financial assets:    
Loans held for investment 2,014,500 2,126,524
Financial liabilities:    
Secured funding agreements 630,299 639,817
Notes payable 104,714 104,662
Secured term loan 149,443 149,393
Collateralized loan obligation securitization debt (consolidated VIEs) 595,105 723,117
Fair Value | Level 3    
Financial assets:    
Loans held for investment 1,870,433 1,944,718
Financial liabilities:    
Secured term loan 135,372 134,024
Fair Value | Level 2    
Financial liabilities:    
Secured funding agreements 630,299 639,817
Notes payable 105,000 105,000
Collateralized loan obligation securitization debt (consolidated VIEs) $ 586,195 $ 705,033
v3.24.1.u1
RELATED PARTY TRANSACTIONS - Narrative (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
loan
quarter
Dec. 31, 2023
USD ($)
Related Party Transaction [Line Items]    
Management fee renewal term (in years) 1 year  
Management agreement termination, termination fee times average annual base management free and incentive fees received 300.00%  
Management fee look back period 24 months  
Loans held for investment $ 2,014,500,000 $ 2,126,524,000
Number of affiliates of company's manager that may originate commercial real estate loans (or more) | loan 1  
Residential    
Related Party Transaction [Line Items]    
Loans held for investment $ 241,500,000 $ 236,700,000
ACREM    
Related Party Transaction [Line Items]    
Base management fees as a percentage of stockholders' equity per annum 1.50%  
Incentive fee payable (not less than) $ 0  
Percentage multiplied to arrive at first value affecting calculation of incentive fees 20.00%  
Previous period for which core earnings are considered to arrive at first value affecting calculation of incentive fees 12 months  
Previous period for product of weighted average price per share and weighted average number of shares of common stock and other shares 12 months  
Percentage multiplied to arrive at difference of first value affecting calculation of incentive fees 8.00%  
Related party transaction, number of fiscal quarter | loan 3  
Period whose fiscal quarters are considered to arrive at first value affecting calculation of incentive fees 12 months  
Minimum cumulative core earnings, number of quarters | quarter 12  
Minimum cumulative core earnings for calculation of incentive fee $ 0  
v3.24.1.u1
RELATED PARTY TRANSACTIONS - Related Party Costs Incurred (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Related Party Transaction [Line Items]      
Payable $ 4,281   $ 4,135
ACREM | Continuing Operations      
Related Party Transaction [Line Items]      
Incurred 3,944 $ 3,762  
ACREM | Continuing Operations | Management fees      
Related Party Transaction [Line Items]      
Incurred 2,768 3,010  
ACREM | Continuing Operations | Incentive fees      
Related Party Transaction [Line Items]      
Incurred 0 0  
ACREM | Continuing Operations | General and administrative expenses      
Related Party Transaction [Line Items]      
Incurred 1,132 732  
ACREM | Continuing Operations | Direct costs      
Related Party Transaction [Line Items]      
Incurred 44 $ 20  
Related Party | Continuing Operations      
Related Party Transaction [Line Items]      
Payable 4,281   4,135
Related Party | Continuing Operations | Management fees      
Related Party Transaction [Line Items]      
Payable 2,768   2,946
Related Party | Continuing Operations | Incentive fees      
Related Party Transaction [Line Items]      
Payable 0   0
Related Party | Continuing Operations | General and administrative expenses      
Related Party Transaction [Line Items]      
Payable 1,458   1,154
Related Party | Continuing Operations | Direct costs      
Related Party Transaction [Line Items]      
Payable $ 55   $ 35
v3.24.1.u1
DIVIDENDS AND DISTRIBUTIONS (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 22, 2024
Feb. 15, 2022
Mar. 31, 2024
Mar. 31, 2023
DIVIDENDS AND DISTRIBUTIONS        
Dividends per share amount declared (in dollars per share) $ 0.25 $ 0.35 $ 0.25 $ 0.35
Total cash dividends $ 13,802 $ 19,345 $ 13,802 $ 19,345
Cash dividends payable (in dollars per share)     $ 0.33  
Supplemental cash dividend payable (in dollars per share)     $ 0.02  
v3.24.1.u1
VARIABLE INTEREST ENTITIES - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 28, 2021
USD ($)
Mar. 31, 2024
USD ($)
loan
Mar. 31, 2023
USD ($)
loan
Dec. 31, 2023
USD ($)
loan
Jan. 11, 2019
USD ($)
Mar. 30, 2017
USD ($)
Variable Interest Entity [Line Items]            
Receivables related to repayments of outstanding principal on previous mortgage assets   $ 6,500   $ 31,000    
Loans held for investment   2,014,500   2,126,524    
Credit risk, financial instrument, maximum exposure   184,800        
ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC | Preferred Stock            
Variable Interest Entity [Line Items]            
Stock issued during period, value, new issues $ 64,300          
Wholly Owned Subsidiary To Parent Company | ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC | Preferred Stock            
Variable Interest Entity [Line Items]            
Stock issued during period, value, new issues   $ 64,300        
Wells Fargo Facility | Notes Payable            
Variable Interest Entity [Line Items]            
Long-term debt           $ 308,800
Wells Fargo Facility | Collateralized Loan Obligations            
Variable Interest Entity [Line Items]            
Long-term debt           $ 32,400
2019 FL3 CLO Securitization | Wells Fargo Facility | Notes Payable            
Variable Interest Entity [Line Items]            
Long-term debt         $ 504,100  
2019 FL3 CLO Securitization | Wells Fargo Facility | Collateralized Loan Obligations            
Variable Interest Entity [Line Items]            
Long-term debt         $ 52,900  
Floating Rate Notes, Weighted Average Coupon Rate, LIBOR Plus 1.85%            
Variable Interest Entity [Line Items]            
Number of properties collateralized for mortgage loan | loan   15 16      
Receivables related to repayments of outstanding principal   $ 469,200   $ 526,000    
Offered Notes | Holdco            
Variable Interest Entity [Line Items]            
Principal amount of certificates retained by wholly owned subsidiary of the entity   58,500        
Offered Certificates | Parent Company            
Variable Interest Entity [Line Items]            
Preferred equity fully funded amount   52,900        
Secured funding agreements | Parent Company            
Variable Interest Entity [Line Items]            
Loans held for investment   111,400        
Secured, Floating Rate Notes | ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC            
Variable Interest Entity [Line Items]            
Aggregate principal amount $ 603,000          
Secured, Floating Rate Notes | Wholly Owned Subsidiary To Parent Company | ACRE Commercial Mortgage 2021-FL3 Ltd. and ACRE Commercial Mortgage 2021-FL3 LLC            
Variable Interest Entity [Line Items]            
Repayments of debt   31,200 $ 0      
Secured, Floating Rate Notes | Wholly Owned Subsidiary To Parent Company | ACRE Commercial Mortgage 2021-FL4 Ltd. and ACRE Commercial Mortgage 2021-FL4 LLC            
Variable Interest Entity [Line Items]            
Repayments of debt   97,100 $ 42,100      
Aggregate principal amount   62,500        
Collateral amount   $ 126,800        
FL4 Mortgage Assets            
Variable Interest Entity [Line Items]            
Number of properties collateralized for mortgage loan | loan   6   9    
Receivables related to repayments of outstanding principal   $ 304,700   $ 404,100    
Receivables related to repayments of outstanding principal on mortgage assets       $ 1,000    
SOFR Plus 8.95% Due Dec 2025 | Residential/Condo | Senior Mortgage Loans | NY | SOFR            
Variable Interest Entity [Line Items]            
Loans held for investment   $ 88,300        
v3.24.1.u1
SUBSEQUENT EVENTS (Details) - USD ($)
May 09, 2024
Jun. 30, 2024
May 07, 2024
Mar. 31, 2024
Dec. 31, 2023
Subsequent Event [Line Items]          
Cash dividends payable (in dollars per share)       $ 0.33  
Outstanding Principal       $ 2,044,948,000 $ 2,158,045,000
Outstanding Balance       885,299,000 894,817,000
Secured term loan          
Subsequent Event [Line Items]          
Outstanding Balance       150,000,000 $ 150,000,000
Subsequent Event | Secured term loan          
Subsequent Event [Line Items]          
Repayments of debt $ 10,000,000        
Outstanding Balance $ 140,000,000        
Office | IL          
Subsequent Event [Line Items]          
Outstanding Principal       46,200,000  
Office | Senior Mortgage Loans | NC | Subsequent Event          
Subsequent Event [Line Items]          
Outstanding Principal     $ 68,600,000    
Industrial | Senior Mortgage Loans | IL | SOFR Plus 4.65%, Due May 2024 | SOFR          
Subsequent Event [Line Items]          
Outstanding Principal       $ 100,700,000  
Forecast          
Subsequent Event [Line Items]          
Cash dividends payable (in dollars per share)   $ 0.25